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Systemic lupus erythematosus (SLE) is an autoimmune disease associated 
with the presence of a wide variety of autoantibodies, including antibodies to 
DNA, RNA, ribonucleoproteins, phospholipids, cytoskeletal proteins and 
histones. The autoimmune phenomena found in SLE are mysterious, both in their 
induction and pathogenic mechanisms. Immune complex formation and their 
deposition in the glomeruli of the kidney is particularly harmful. The existence of 
autoantibodies in SLE specifically reactive with sequences and structures in RNA 
have also been demonstrated. 
Reactive oxygen species (ROS) are formed continuously in living cells as 
a consequence of normal metabolic and biochemical reactions, as well as in 
certain pathological conditions. ROS are formed from oxygen in one electron 
reduction reactions and include superoxide (O^'"), hydrogen peroxide (H-O^) 
and hydroxyl radical (OH). Among the ROS, OH is the most damaging and can 
virtually react with any macromolecule it encounters. In vivo, hydroxyl radicals 
are formed by ionizing radiations or through the Haber-Weiss or Fenton 
reactions. Thus, causing DNA damage leading to strand breaks, base damage and 
conformational changes. 
Native DNA is known to be a weak immunogen. It has been shown that 
modification of DNA renders it highly immunogenic. The hypothesis that ROS-
modification of DNA is involved in the development of autoantibodies in SLE, 
has been supported by the enhanced reactivity of SLE anti-DNA autoantibodies 
to ROS-DNA. In view of these, the possible association of the ROS-modified 
and native polyribohomopolymer, polyinosinic acid [poly(I)] in the SLE disease 
activity has been speculated. 
In the present study, polyinosinic acid [poly(I)] was modified with hydroxyl 
radical, generated by UV light in the presence of hydrogen peroxide. UV-
absorption and difference spectroscopy was used to analyse the modifications/ 
perturbations incurred on poly(I). Modified poly(I) sample showed a marked 
hypochromicity at 248 nm over the unmodified poly(I), reflecting the modification 
of hypoxanthine base in ROS-poly(I). The elimination of the expected negative 
peak at the Xmax in between 200-280 nm in UV difference spectrum of the 
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modified poly(I) suggests the loss of chromophoric group, thus showing the ROS 
induced damage of the hypoxanthine base in poly(I). On formation of complex 
with poly(C), a change in absorbance ratio was observed with poly(I).poly(C) 
showing a ratio of 1.13 and ROS-modified poly(I).poly(C) of 0.98. Thus, reflects 
the occurrence of modification in poly(I) due to ROS. 
Analysis and computation of thermodynamic parameters suggest the 
introduction of partial compactness in ROS-poly(I) at the site of ROS-
modification, in contrast to native poly(I). Thermodynamically, ROS-poly(I) was 
found to be more stable than native poly(I). 
Sephadex G-200 gel chromatography, agarose gel electrophoresis, 
densitometric scanning and gel diffusion were the techniques employed to detect 
the formation of strand breaks and base modification. Sephadex G-200 gel 
chromatographic pattern shows the modification of poly(I) to an extent of 57.8%. 
Enhanced mobility of ROS-poly(I) with decreased intensity is attributed to single 
strand breaks formation and base modification in poly(I) on exposure to OH 
radical. Further, densitometric scanning and gel diffusion pattern ascertain the 
enhanced mobility of ROS-poly(I) due to strand breaks formation and generation 
of low molecular weight species. 
Photochemical changes are found to occur in purine and pyrimidine bases 
on attack of OH radical. The release of hypoxanthine base from poly(I) was 
detected by UV absorption spectra of acid hydrolysed poly(I), showing a Xm&x 
at 250 nm, typical of hypoxanthine base. Broadened absorption maxima at 250 
nm in case of acid hydrolysed ROS-poly(I) showed base modification. These 
results were substantiated by UV difference spectroscopy. Ion exchange 
chromatography of the acid hydrolysed native and ROS-poly(I) suggest a 
modification of upto 71.8% in hypoxanthine base by "OH and hence confirms the 
modifying effect of ROS. 
To raise antibodies, rabbits were immunized intramuscularly with native and 
ROS-modified poly(I) complexed with methylated bovine serum albumin. Both 
the polymers were found to be potent immunogens, inducing high titer antibodies. 
The specificity of the induced antibodies were ascertained by competition 
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immunoassay, using poly(I) and ROS-poly(I) as inhibitors and were found to be 
highly specific towards the respective immunogen. 
Experimentally induced antibodies exhibited polyreactivity, a property 
commonly associated with SLE anti-DNA autoantibodies. Anti-native poly(I) 
antibodies showed preferential binding to native forms of DNA, RNA, 
ribohomopolymers and guanine base (as inhibitors) in comparison to their ROS-
modified counterparts. Anti-ROS-poly(I) antibodies showed specificity towards 
ROS-modified conformers as inhibitors. 
A group of SLE sera were investigated for the evaluation of anti-DNA 
autoantibody titer. SLE sera from 14 patients showing high titer anti-DNA 
autoantibodies were analysed for their specificity towards native DNA by 
inhibition ELISA. The binding specificity of SLE anti-DNA autoantibodies with 
ROS modified and native poly(I) was analysed by ELISA, gel retardation assay 
and quantitative precipitin titration. Direct binding ELISA results show 
preferential binding of SLE autoantibodies to ROS-poly(I) in comparison to 
native poly(I). Further, inhibition ELISA reiterates the direct binding results. Gel 
retardation assay further substantiated the binding of native and modified poly(I) 
with anti-DNA autoantibodies. Protein A-Sepharose 4B purified SLE IgG 
showed appreciable binding to native and modified poly(I). The binding affinity 
of modified and unmodified poly(I) with SLE IgG was calculated usingXangmuir 
plot. The association constant (Ka) for ROS-poly(I) was found to be highest, 
followed by native DNA and native poly(I), respectively. The binding patterns 
of SLE autoantibodies obtained from different patients were remarkably similar, 
indicating the recognition of the modified polymer by naturally occurring SLE 
anti-DNA autoantibodies. The results suggest that the photochemical modification 
of poly(I) cause perturbations, resulting in the generation of neo-epitopes making 
it a potential immunogen. 
Deposition of the immune complexes between DNA and autoantibodies to 
DNA in kidney has been considered to elucidate the inflammatory reaction in 
lupus nephritis. Rats immunized with native and modified poly(I) induced high 
titer antibodies. Immunofluorescence of the kidney sections of rats showed the 
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Friedrich Meischer, a Swiss biologist, in 1879 carried out the first 
systematic chemical studies of cell nuclei. Since then DNA has occupied a 
centre stage in various biochemical investigations. James Watson and Francis 
Crick in 1953 first enunciated the double helical structure of DNA with the 
axis of helix running through the Watson-Crick base pairs. While this model 
of DNA, regarded as B-DNA, remains close to the accepted structure of the 
DNA molecule in solution, X-ray diffraction studies have shown that DNA 
can have alternative conformations such as A-DNA and C-DNA within the right 
handed family (Adams et al., 1981). The idea that the structure of DNA 
corresponds to a homogeneous double helix under native conditions has 
gradually given way to a modern view that the local conformation of DNA is 
variable, reflecting the conformational preference of the local sequence of B-
DNA double helix in a DNA hexamer with a sequence d(CGCGCG). The two 
strands of the duplex were anti-parallel and connected by Watson-Crick base 
pairs, but the helix was left handed. The backbone had zigzag shape and thus 
termed as Z-DNA. Synthetic polynucleotides have been described by Felsenfeld 
et al. (1957) to form triple stranded structures spontaneously. They have 
also been found to exist in DNA using a variety of hydrogen bonding 
arrangements in the major groove of B-DNA. For example, a triple stranded 
DNA has been found as an intermediate in the action of E. coli recombination 
enzyme Rec A (Camerini-Otero and Hseih, 1993). Rich in 1958 gave the idea 
of quadruple stranded nucleic acids (Rich, 1958; Zimmerman et al., 1975). 
The DNA helix is both deformed and made deformable by its local base 
sequence. That is, some regions of DNA may be given a particular local 
conformation by sequence, where as others may be made especially susceptible 
to a change in the conformation when the helix interacts with neighbours, a 
protein molecule, drug molecule or an adjacent DNA helix in a crystal lattice. 
Antigenicity of DNA 
DNA is a complex macromolecule with immunologic properties that have 
been both misconstrued and under-appreciated. The antigenic property of 
nucleic acids was recognised much later than those of proteins and 
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polysaccharides. Anti-DNA antibody studies have been underway since about 
1957, when DNA was identified as a reactant for SLE autoantibodies (Cepellini 
et al., 1957; Meischer and Strassie, 1957; Robbins et al., 1957). The evidence 
that DNA served as the antigen was established by using highly purified DNA, 
RNA not reacting to the autoantibodies, loss of reactivity after digestion with 
deoxyribonuclease (DNAse) but not with ribonuclease (RNAse or proteolytic 
enzymes). The studies were further accelerated when in early 1960s, methods 
were developed for experimental induction of antibodies to nucleic acids 
(Erlanger and Beiser, 1964; Plescia et al., 1964; Levine et al., 1966). 
Studies on the antigenic specificity of anti-DNA antibodies have enforced 
the view that DNA is immunologically simple and bland. Exogenous native B-
DNA has not been found immunogenic in experimental animals. Immunization 
of experimental animals with denatured DNA, synthetic nucleic acid polymers 
like poly(dT), poly(dC), poly(A), poly(I), poly(G), dsRNA and left handed Z-
DNA induced antibodies that react selectively with the immunogen (Stollar, 
1986). 
The notion that DNA is immunologically inactive derives primarily from 
efforts to replicate SLE by immunization of normal animals with DNA. 
Mammalian DNA elicit poor responses to single stranded DNA and fails to 
induce antibodies against native or double stranded DNA, the serologic 
hallmark of SLE (Madaio et al., 1984), when presented with the protein carrier, 
methylated BSA (MBSA), and administered in adjuvant. However, recent 
studies have shown that DNA complexes with synthetic peptide Fus-1 can 
induce an anti-dsDNA response in mice (Desai et al., 1993). Anti-DNA 
antibodies may also result by autoimmunization with chromatin, rather than 
nDNA (Theofilopoulos, 1995). 
Due to several unique features, DNA has a direct bearing on its immune 
reactions. In nature, it exists in two different conformations, a double stranded 
(right handed double helix) and single stranded conformation apart from left 
handed DNA or Z-DNA (Wang et al., 1979). A second feature of DNA is 
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its multi-determinant nature and third is its polyanionic nature. 
The left handed Z-DNA is a potent immunogen (Lafer et al., 1981; Madaio 
et al., 1984) inducing antibodies that are selective and specific and do not 
react with nDNA or ssDNA (Zarling et al., 1984). Modified DNA or helical 
structures that differ significantly from B-DNA, are much stronger immunologic 
stimuli than nDNA. Calf thymus DNA modified with drugs, hormones, free 
radicals etc. has been reported to produce antibodies against one modified 
polymer (Ara and Ali, 1993; Moinuddin and Ali, 1994; Arjumand et al., 
1995). Several polynucleotides differing in conformation from the B-DNA 
helical conformation are much stronger immunogen than native B-DNA (Braun 
and Lee., 1988). Polynucleotides of B-conformation become immunogenic after 
modification with furocoumarins (Arif and Ali, 1996). 
In the past few years, the perspective on the immunologic properties of 
DNA has been substantially revised. This shift reflects compelling evidence that 
bacterial DNA, in contrast to mammalian DNA, can induce a variety of 
responses in both normal humans as well as in animals. In contrast to the normal 
dogma that anti-DNA antibodies are prevalent in lupus alone, a surprising 
finding was the recognition of bacterial DNA from two species Micrococcus 
lysodeikticus and Staphylococcus epidermidis by normal human sera 
(Karounos et al., 1988). Studies have also demonstrated that complexes of 
bacterial DNA and MBSA are immunogenic in normal mice (Gilkeson et al., 
1989). In contrast to normal mice, autoimmune NZB/NZW mice when 
immunized with either bacterial DNA or BK viral DNA, produce cross reactive 
antibodies to mammalian dsDNA (Fredriksen et al., 1994; Gilkeson et al., 
1995). These induced antibodies have specificities comparable to naturally 
occurring lupus anti-DNA autoantibodies. While confirming the enhanced 
immunogenicity of foreign DNA, these findings also demonstrate a unique 
responsiveness of autoimmune mice to DNA. 
Free Radicals 
A chemical species possessing an unpaired electron is defined as a 
free radical (Halliwell and Gutteridge, 1989). The unpaired electron drastically 
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alters the chemical reactivity of the molecule, usually making it more reactive 
than the corresponding non-radical form (Halliwell, 1994). 
It is a well established fact that free radicals and other reactive oxygen 
species (ROS) are continuously produced in vivo. Reactive oxygen species 
generated due to electron reduction of molecular oxygen includes not only 
oxygen centred radicals such as superoxide (02~) and hydroxyl radical (OH) 
but also some non-radical derivatives of oxygen such as hydrogen peroxide 
(H202) and singlet oxygen ( '02) . 
ROS are highly reactive and have extremely short half lives. This reactivity 
is due to the unstable electronic configuration of the radicals. They readily 
extract electrons from other molecules, which in turn become a free radical 
and thus highly reactive, perpetuating a chain reaction. 
In living cells, free radicals are generated by endogenous sources (e.g. 
oxidant enzymes, phagocytic cells) and also by exogenous sources (e.g. 
redox-cycling drugs, ionizing radiation) (Halliwell and Gutteridge, 1989). Free 
radicals can damage all biological molecules including cellular DNA (Ballmer 
et al., 1994) and thus may be mutagenic and carcinogenic (Moody and Hassan, 
1982; Brawn and Fridovich, 1985; Weitzman et al., 1985). In recent years, 
considerable interest has been paid to the damage that can be done by the 
generation of ROS in living system (Fridovich, 1986; Breimer,1990). 
Arguably, the most important free radicals in biological systems are radical 
derivatives of oxygen. Reduction of oxygen by a single electron will produce 
the superoxide anion radical (superoxide). 
0 2 + e > 0 2 " 
Reduction with two e" would yield hydrogen peroxide (H202). 
0 2 + 2e- + 2H+ > H202 
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Hydrogen peroxide is an important compound in free radical biochemistry. 
It is ubiquitous in biological systems and can be formed as a consequence of 
a variety of metabolic processes. 
Among the ROS, hydroxyl radicals (OH) are extremely dangerous species 
and react with cellular components with very high rate constants. The most 
important reactions are hydrogen abstraction, addition and electron transfer 
(Hutchinson, 1985; Schulte-Frohlinde and von Sonntag, 1985). In living 
organisms, hydroxyl radical is produced by at least two mechanisms. 
Reaction of transition metal ions with H202 in Fenton-like reactions 
(Cohen, 1985) results in the production of OH. 
Mn+ + H202 > M(n+1)+ + OH +'OH 
Secondly, through homolytic fission of water due to background exposure 
to ionizing radiation (von Sonntag, 1987). 
H20 > H20'+ + eaq. 
H20*+ + H20 > H30+ 'OH 
Hydroxyl radicals have been implicated as the causative agent in 
deleterious processes such as gene mutation (Okada, 1970), cell transformation 
(Borek, 1985) and cell death (Painter, 1980). 
Cellular Damage by Free Radicals 
In cells, free radicals are generally produced by electron transfer 
reactions. These can be mediated by the action of enzymes or non-enzymatically 
often through the redox chemistry of transition metal ions. 
Free radical production in animal cells can either be accidental or 
deliberate. Under normal circumstances, the major source of free radical in cells 
is electron 'leakage' from electron transport chains such as those in 
mitochondria (Haiku et al., 1993) and in the endoplasmic reticulum, to 
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molecular oxygen, generating superoxide. Free radical production in cells can 
be greatly increased by certain toxic foreign compounds. DNA is an important 
target for free radicals since it is clearly of major significance for cell function. 
The chemistry of DNA damage by several ROS has been well characterized 
in vivo (von Sonntag, 1987; Dizdaroglu, 1993; Box et al., 1995). Apart from 
free radicals, DNA is also inflicted by radiations and chemicals (Simic and 
Jovanovic, 1986). H202 induced degradation of DNA in vitro and in vivo 
has been demonstrated by decreased viscosity, increased single-strand and 
double-strand breaks, formation of ammonia and inorganic phosphate and 
base release (Scholes and Weiss, 1953; Rhease and Freese, 1968; Massie et 
al., 1972; Lesko et al., 1980; Meneghini and Hoffman, 1980; Milligan and 
Ward, 1994). 
In the presence of ferrous or copper ions, hydrogen peroxide generates 
OH radical through Fenton or Fenton-like reactions. The radical is also 
generated by exposure to UV light. The ROS generated by these methods 
damage and cleave DNA (von Sonntag, 1987; Goldstein et al., 1993). The 
hydroxyl radical is fearsomely reactive species causing extensive damage to 
biological macromolecules and deleterious reactions in vivo (Imlay and Linn, 
1988; Shi, 1994 a & b). Oxidative damage to DNA includes a range of 
specifically oxidized purines and pyrimidines (Dizdaroglu, 1994), strand breaks 
(Dizdaroglu, 1993), sister chromatid exchanges and subsequent production of 
clastogenic factors (Emerit et al., 1985) and conformational changes (Allan et 
al., 1988). DNA associated copper ions in cells might also react with phenolic 
compounds to produce ROS and electrophillic phenolic intermediates (Li and 
Trush, 1994; Li et al., 1994; Spencer et al., 1994). This interaction could 
cause a range of DNA lesions including base modification, strand breaks and 
phenol adducts to the DNA bases, all of which might contribute to the 
carcinogenicity of certain phenolic compounds. In moving from single stranded 
RNA or DNA, to double stranded RNA or DNA the rate of reaction with 
hydroxyl radical decrease from poly A, C, U (Micheals and Hunt, 1973; 
Masuda et al., 1980) and ssDNA (Liphard et al., 1990) to poly(U+A) and 
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dsDNA (Micheals and Hunt, 1973). Among the five major components of DNA, 
thymine and cytosine are most susceptible to OH damage, followed by adenine, 
guanine and deoxyribose (Saul et al., 1987). 
The hydroxyl radicals react with uracil derivatives preferentially giving the 
C5-OH adduct radicals. With thymine also, the products are C5-OH and C6-
OH adduct radicals. But here, the hydroxyl group can also, to a lesser extent, 
abstract hydrogen from the methyl group giving a stable allyl radical. The major 
Cs-OH adduct is oxidised at C6 and the resulting cation quenched with water 
to give the cis and trans isomers of 5,6 dihydrothymine (or thymine glycol) 
(Fujita and Steenken, 1981). Alternatively, it abstracts hydrogen from DNA 
giving 5-hydroxy-5,6-dihydrothymine (Deeble and von Sonntag, 1984; Deeble 
et al., 1986; Karam et al., 1988). The base mediated hydrogen abstraction 
from the neighbouring sugars, mostly via this C-6 radical is thought to account 
for a major part of radiation induced strand cleavage in ds-DNA, 
[poly(dA).poly(T)], ssDNA, poly(T) (Karam et al., 1988) and ssRNA 
[poly(U)] ( Deeble and von Sonntag, 1984; Lemaire et al., 1984; Deeble et 
al., 1986). Release of intact thymine glycol from DNA can be assayed by 
HPLC (Demple and Linn, 1980). In urine they serve as an indicator of 
endogenous DNA damage (Cathcart et al., 1984). Most oxidation products of 
cytosine are analogous to those detected for thymine, forming several products 
including cytosine glycol and 5,6 dihydrocytosine. After H202 treatment of 
cultured mammalian cells, 5,6 hydrated cytosine in DNA predominates over 
thymine glycol (Dizdaroglu, 1992). Upon deamination, cytosine glycol forms 
uracil derivatives, which preferentially base pairs with adenine instead of 
guanine and hence enhances the mutagenic effect of cytosine hydrates over 
thymine glycol. In case of guanine, hydroxyl radicals have been shown to add 
to C-4, 5 and 8 of guanine to give G4-OH\ G5-OH' and Gg-OH\ The total 
yield of oxidizing and reducing radical was greater than 100% of the hydroxyl 
radical produced (56% are reducing, 51% are oxidising). Thus, the hydroxyl 
radical adducts of guanine exhibit "redox ambivalence" (Steenken, 1989). 
Reduction gives the ring saturated hemi-aminal, whose ring opens upto 
formamido-pyrimidine (FAPy) compound. Studies have found that FAPyG is 
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formed in DNA (Fuciarelli et al., 1990), chromatin (Gajewski et al., 1990) 
and in human cells (Nackerdien et al., 1992). Alternatively, oxidation of the 
C-4 and C-2 resonance forms of Gg-OH* and loss of a proton rearomatizes 
the imidazole ring giving 8-hydroxyguanine (Steenken, 1989). 8-hydroxyguanine 
is one of the most abundant base lesions formed by UV (Floyd et al., 1988) 
and ionizing radiations (Kasai et al., 1986; Pllaum et al., 1994) and is highly 
mutagenic (Cheng et al., 1992; Moriya, 1993). This derivative has been 
isolated from irradiated DNA (Dizdaroglu, 1985; Fuciarelli et al., 1990; Rosen 
et al., 1996), chromatin (Gajewski et al., 1990) and human cells (Kasai et 
al., 1986; Nackerdein et al., 1992). Methods such as HPLC and GC-MS have 
been described to measure 8-oxo-dG (Cundy et al., 1988; Lunec et al., 1994) 
and is found to be increased with age in liver, kidney and intestine, but not 
in brain or testis. (Fraga et al., 1990; Floyd, 1993) in rats. The initial and 
intermediate radicals formed are analogous to that of guanine, though their 
redox properties differ slightly. 
Oxidative damage to DNA not only includes a range of specifically 
oxidized purines and pyrimidines, but also alkali labile sites and strand breaks. 
The hydroxyl radical is also found to attack the phosphodiester backbone of 
DNA. The damage caused can displace bases, oxidize deoxyribose and fragment 
the sugar (Demple and Harrison, 1994). Radical attacks at CI oxidizing it to 
carboxylate to form deoxyribonic acid, eliminating the apparently undamaged 
base (Dizdaroglu et al., 1977). While, if C4 is attacked, 4-ketodeoxyribonate 
is formed with base displacement (Dizdaroglu et al., 1977). Both these lesions 
leave DNA intact, but the lability of these abasic sites in alkali allow their 
release from oxidized DNA (Dizdaroglu et al., 1977; Beesk et al., 1979). 
Repair enzymes called DNA-N-glycosylases remove damaged bases resulting 
in apurinic or apyrimidinic (AP) sites which may be mutagenic within the DNA 
chain (Loeb and Preston, 1986), specifically, when used as a substrate for DNA 
synthesis with AP sites led to the preferential insertion of adenine opposite 
the lesion (Kunkel et al., 1983), leading to mutations, where the lost base 
was other than a thymine. AP sites do also inhibit DNA synthesis (Sagher and 
Strauss, 1983). However, sugar damage leading to strand cleavage, such as 
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3'-phosphoglycolate ends chain or 3'-phosphate ends cannot be acted upon 
by DNA polymerases either as a template or as a primer prior to enzymatic 
hydrolysis of the 3'hydroxyl (Henner et al., 1983). The double strand breaks 
caused by such altered sugars are lethal leading to cell death (von Sonntag, 
1987; Ward et al., 1990). 
DNA Damage and Repair 
Oxidative DNA damage impose a significant and constant threat to aerobic 
organisms. Aerobic bacteria, yeast and mammalian cells are supplied with a 
series of enzymes that can attack these oxidative damages. However, DNA from 
human cells and tissues contain low levels of DNA base damage products 
(Ames, 1989; Malins and Haimanot, 1991; Halliwell and Dizdaroglu, 1992; 
Bashir et al., 1993; Jaruga et al., 1994; Adachi et al., 1995), suggesting 
that these enzymes do not achieve complete removal of modified bases, 
perhaps because they operate at close to maximum capacity in vivo. General 
repair mechanisms act as secondary repair pathways and can handle more 
complex lesions (Tainer et al., 1995). 
DNA glcosylases exist for the repair of several DNA base lesions, 
including oxidized, methylated and deaminated bases. Enzymes of this class 
initiate repair by hydrolyzing the base- sugar (N-C glycosidic) bond of modified 
or incorrect bases. These enzymes excise bases and subsequently, 
phosphodiester bonds on each side of the abasic site which are incised by 
endonucleases, allowing insertion of intact nucleotide. Endonuclease III has 
both glycosylase and endonuclease activities for repair of oxidized pyrimidines. 
E. coli formamidopyrimidine glycosylase (Fpg/Mut M) is a 31 kd enzyme has 
a DNA glycosylase activity. Fpg releases the unmethylated FAPy derivatives 
of both adenine and guanine generated by ionizing radiation (Breimer, 1984). 
Fpg was found to act as an efficient 8-oxo-G glycosylase (Tchou et al., 1991). 
Fpg deficient strains were reported to contain a steady state level of 8-oxo-
G in their DNA six times higher than measured for wild type cells (Bessho 
et al., 1992). In humans, a similar two step pathway yielding 8-oxo-dG has 
been identified, in addition to repair of 8-oxo-dG by single step excision of 
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the complete nucleotide (Bessho et al., 1993). Mut T, a dGTPase (Bhatnagar 
el al., 1991) preferentially hydrolyzes 8-oxo-dGTP (Maki and Sekiguchi, 
1992) eliminating 8-oxo-G, the mutagenic precursor from the nucleotide pool. 
A similar activity has been described in human cells (Mo et al., 1992; Sakumi 
et al., 1993). Hypoxanthine glycosylase releases deaminated adenine from DNA 
and has been detected in E. coli (Karran and Lendahl, 1978) and human cells 
(Myrnes et al., 1982; Dehayzya and Sirover, 1986). Hypoxanthine DNA 
glycosylase does not recognize various mismatched base pairs (G:T, A:G or 
A:C), but specifically acts on dIMP in DNA (Dianov and Lindahl, 1991). 
The same enzymes that cleave AP sites arising from all DNA glycosylases 
also initiate the repair of oxidized abasic sites and deoxyribose fragments 
formed by free radical attack. Exonuclease III of E. coli is the major AP 
endonuclease (Gossard and Verly, 1978). It has a ribonuclease H activity 
(Rogers and Weiss, 1980). The activities of exonuclease III show a near 
absolute preference for double stranded substrates. The AP exonuclease III 
can digest from internal nicks (Richardson et al., 1964; Rogers and Weiss, 
1980) and also degrades linear DNA from both 3' ends (Richardson et al., 
1964). The AP endonuclease cleaves hydrolytically on the 51 side of base-
free deoxyribose (Rogers and Weiss, 1980) which leaves an abasic 5' terminal 
deoxyribose-5-phosphate. General repair systems that recognize diverse DNA 
lesions also act on oxidative damages. UVr ABC system in E. coli acts as 
a secondary defence against oxidative damages. In humans, DNA photodamages 
account for much of the cellular and genetic deterioration in individuals with 
the inherited repair deficiency disease Xeroderma pigmentosum (Friedberg, 
1985). The damage specificity of the mammalian excision repair system, which 
is defective in this disease is reminiscent of the UVr-ABC system of E.coli 
and the mammalian repair mechanism also includes many components 
(Hoeijmakers, 1993; Saricar and Tang, 1993). It has been found that human 
excision repair system can act at lesions distinct from those recognized by 
endonuclease III (AP sites thymine glycol etc.) and Fpg MutM protein (8-
oxoguanines and FAPy residues) (Satoh et al., 1993). It was speculated that 
these damages might be dihydrothymine crosslinks (Dizdaroglu, 1992), 8,5'-
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cyclodeoxyadenosines (Raleigh et al., 1987) or purine-purine interstrand 
crosslinks (Carmicheal et al., 1992). 
For oxidative damages, recombinational repair is crucial for interstrand 
crosslinks and double strand breaks. Repair of double-strand breaks has a 
strong requirement for recombination proteins for obvious reasons (Petes et 
al., 1991; West, 1992). Such breaks are among the major products formed 
by ionizing radiation (von Sonntag, 1987). 
Autoimmunity and Autoimmune Diseases 
The presence of antibodies in the sera of physiologically healthy individuals 
can be traced back to as early as 1900. Subsequent studies have shown the 
presence, in normal individuals, of antibodies reactive with a variety of cellular 
and humoral constituents. These antibodies, subsequently termed natural 
antibodies were found, in some cases, to react with self constituents such as 
sperm, brain and skin antigens, that under normal conditions are not found in 
the circulation and, therefore, are not exposed to immune system. With the 
general acceptance of Burnet's clonal selection hypothesis in the 1960s, studies 
on spontaneously occurring antibodies diminished considerably. On the basis 
of this theory, which put forth the idea that lymphocyte populations capable 
of reacting with self components are deleted during embryonic life and provide 
self tolerance, synthesis of autoantibodies reacting with self components does 
not correspond to physiological process, but is the result of pathological 
situations (Burnet, 1959). 
Normally, immunologic attack is directed against agents which are foreign 
such as bacteria, viruses, parasites and some internal changes, while it does 
not respond to self antigens. However, under varied stresses, the individual's 
own tissue component may become a participant in immunologic reactions and 
injury, resulting in clinical disease. Thus, autoimmune diseases are those which 
result from immunologic reactions, humoral and/or cellular or a combination of 
both. A hallmark of most autoimmune diseases is the presence of autoantibodies 
against self antigens. Autoimmune diseases may be classified in different ways 
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according to the parameters considered. It may be T cell and or antibody 
mediated, organ specific or systemic autoimmunity. It may destroy, mimic or 
enhance the target and can range in severity from being mild to fatal (Minard, 
1989). 
It has long been hypothesized that the development of the immune system 
is triadic in nature, useless cells are discarded, useful cells are retained and 
dangerous cells are destroyed or inactivated. Recently, studies with transgenic 
and endogenous superantigen (S-Ag) expressing mice have strongly favoured 
this hypothesis with the ultimate outcome likely to be dependent on the degree 
with which antigen receptors react with self constituents. Specifically, it appears 
that as T cells mature in thymus, those that rearrange and display self major 
histocompatibility complex (MHC) and peptide reactive T cell receptor of 
certain affinity/avidity are maintained and propagated within the thymus (positive 
selection) but prior to their export to the periphery, those with receptors of 
dangerously high affinity/avidity are eliminated or inactivated (negative 
selection) (Nossal, 1994; Aston- Rickardt and Tonegawa, 1994; von Boehmer, 
1994). Through these and other editing processes (Goodnow, 1992), a state 
of self tolerance is achieved. However, despite the recent acquisition of 
extensive information relating to the mechanisms of self tolerance, the 
understanding of the mechanisms leading to pathogenic autoimmunity is still 
fragmentary and incomplete. No single theory can adequately explain all 
features of autoimmune diseases. Perhaps, the best approach as suggested by 
Shoenfeld and Isenberg (1989), is to consider the wide spectrum of autoimmune 
diseases as the "mosaic" of autoimmunity with its many pieces, genetic, 
hormonal, immunological and environmental leading to diverse diseases. 
Causes of Autoimmune Diseases 
Despite enormous insights about immune reactions, the precise 
mechanisms underlying initiation of autoimmune reactivity are not yet completely 
understood, nevertheless, certain factors are known to be involved. 
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(a) Role of genetic factors 
It is well known that autoimmune diseases, in general, show a highly 
significant familial predisposition. Generally accepted hypothesis at present 
proposes the existence of a primary autoimmune gene, not part of the major 
histocompatibility complex (MHC) on the sixth chromosome, but located in 
another region not yet known. According to this hypothesis, the HLA genes 
function as secondary genes to allow expression of specific autoantibody or 
the respective disease state (Bias et al., 1986). The association between certain 
autoimmune diseases and HLA antigens is well documented. The reported 
association between systemic lupus erythematosus (SLE) and DR2 and DR4 and 
Sjogren's syndrome and DR2 and/or DR3 etc. are but examples of this 
relationship (Braun and Zachary, 1988). 
(b) Hormonal factors 
It is well known that as compared to males, females are more prone to 
autoimmune diseases. In certain diseases, the ratio of female to male often 
reaches to 10:1. Sex hormones, thymic hormones and corticosteroids play a 
significant role, though the mechanism involved is still not clear. It has been 
reported that testosterone and thymic hormones enhance CD8+ T cells (Lahita 
and Kunkel, 1984), whereas, estrogen is found to suppress this function (Talal 
and Ahmad, 1987). Female relatives of patients with certain autoimmune 
diseases have been reported to demonstrate a significant prevalence of 
autoantibodies and suppressor T cell defects (Miller and Schwartz, 1982). 
(c) Immunor emulation 
The immune response is controlled mainly by the regulatory influence of 
T-lymphocyte subsets, T-helper and T-suppressor cells and idiotopes. There 
are also many components which have not been identified yet that can up or 
down regulate cells of the immune system. Normally, B cells with potential to 
produce autoantibodies are held in check by a lack of helper cells or an 
abundance of suppressor cells. In autoimmunity, an imbalance of this regulatory 
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system is manifested. In normal individuals, the ratio of T-helper to T-
suppressor cells in peripheral blood tends to be approximately 2 :1 , whereas, 
in case of autoimmune disease, it shoots to 10 or 15:1, particularly during the 
acute or active phase of the respective disease. Wide variety of autoimmune 
diseases such as SLE, Sjogren's syndrome, progressive systemic sclerosis 
(PSS) or scleroderma, rheumatoid arthritis (RA), pernicious anaemia and many 
others are found to show an increased T-helper/T-supressor ratio. 
Abnormalities of immune regulation in PSS due to an excess of helper cell 
function have been demonstrated (Krakauer et al., 1981). Various foreign 
organisms may also upset the balance of immunoregulation, for example switch 
from TH1 like lymphokine pattern to TH2 type pattern seen in HIV infection 
is paralleled by an increased number of B cells and hypergammaglobulinemia 
and the switch is commonly seen in autoimmune diseases as well (Levinson, 
1994). 
(d) Tolerance 
Tolerance is accomplished through three mechanisms: thymic education, 
thymic deletion and peripheral tolerance. Thymus is the major site for self-
nonself discrimination. It is here that the T cell repertoire is determined. Some 
cells are programmed to die (negative selection) while others are not (positive 
selection) (Adorini, 1993). Errors in central or peripheral tolerance at the T 
or B cell level have also been suggested as probable causes for autoimmunity. 
Sprent (1993) suggested that autoimmunity in neonatally thymectomized mice 
is most likely to be caused by quantitative deficiencies of T cell as well as 
susceptibility to infection and consequent release of self antigens from the 
infection site. It has also been suggested (Rose, 1994) that thymus is the critical 
time keeper with aging process with respect to immune responses. As the thymic 
cortex atrophies, the response to foreign antigens declines, whereas, the 
response to self antigen rises, generating the aging paradox. 
(e) Polyclonal activators 
Polyclonal B and/or T cell ativation has been considered a contributing 
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or initiating mechanism of autoimmunity, particularly in systemic diseases. 
Proposition that polyclonal B cell activators can induce autoantibodies is 
predicted on the existence of non-deleted self reactive B cell and/or 
developmentally arrested anergised B cells, that might become active upon 
appropriate stimulation. It was suggested that in some models of autoimmunity, 
there is predominant engagement of Th-2 cells that promote the humoral 
response (IL-4 hyperproduction) (Goldman et al., 1991). Another suggestion 
proposed was polyclonal stimulation of a large set of T cells by bacterial/viral 
S-Ag (Friedman et al., 1991). T cells that react with MHC class II bound 
S-Ag on B cells may mutually stimulate the S-Ag displaying B cells, thereby 
leading to production of polyclonal immunoglobulins and in some instances, 
autoantibodies (He et al., 1992). 
(f) Other factors 
Another proposition for the mechanism of induction of pathogenic 
autoimmune response addresses molecular rather than anatomic sequestration, 
and relates to the presence of cryptic self determinants (Gammon et al., 1991). 
According to this proposition, a small minority of dominant determinants in self 
proteins are involved in negative selection, leading to tolerance, while the 
subdominant/cryptic determinants do not induce tolerance and, therefore, 
a large cohort of self reactive T cells exist. Epitope crypticity may result on 
account of ineffective processing or dominance of flanking epitopes that 
compete for binding to the same MHC molecule or otherwise hinders access 
to the MHC or TCR. On initiation of response against cryptic determinants, 
'determinant spreading', that is secondary response to additional inter and 
intramolecular determinants occur (Lehman, 1993). In expanding upon this 
concept, inappropriate expression of developmental or differentiation antigens 
may also led to an autoimmune response. 
Viruses also have been found to have close association with autoimmune 
diseases of human and animals (Kreig and Steinberg, 1990; Steinberg et al., 
1990; Kreig et al., 1989; 1991). The mechanisms by which viruses and perhaps 
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other infectious agents initiate autoimmune phenomena are probably complex 
and may include structural similarity, increased HLA expression, polyclonal 
B cell activation and alteration of self antigens (Shoenfeld and Isenberg, 1989). 
An immune response mounted by the host sequence could lead to autoimmunity 
and in some cases, tissue injury and disease. 
Systemic Lupus Erythematosus 
Systemic lupus erythematosus (SLE) is an archetype of the systemic 
autoimmune disorder characterized by the prodution of antibodies to a diverse 
array of nuclear antigens (antinuclear antibodies). The disease manifests itself 
with a variety of fascinating clinical and immunological features. The major 
serological marker of SLE, antibodies to DNA, were distinguished by four 
different groups as early as 1957 (Cepellini et al., 1957; Meischer and Strassie, 
1957; Robins et al., 1957; Seligman, 1957). During the next 20 years, a large 
panoply of antibodies were identified in the serum of lupus patients. Patients 
with SLE are found to produce ANA, with over 95% of patients showing a 
positive fluorescent anti-nuclear antibody (FANA) test (Pisetsky, 1994). 
Radioimmunoassays are more specific for antibodies to undenatured double 
stranded DNA (Takeuchi et al., 1997). Only anti-DNA and anti-Sm are unique 
to SLE and serve as criteria in disease classification. Despite the presence of 
antibodies to both ssDNA and dsDNA, most clinical assays are designed to 
detect antibodies to dsDNA because of increased specificity for diagnosis 
(Pisetsky, 1993). Among the various antinuclear antibodies found, those specific 
for DNA (anti-DNA antibodies) are highly characteristic of SLE, serving as 
a marker of both diagnostic and prognostic significance. Furthermore, anti-
DNA antibodies play a direct role in tissue injury (eg. nephritis) that is again 
characteristic of SLE. Anti-DNA antibodies have also been shown to be 
enriched in glomerular eluates of SLE patients. Foremost amongst the 
autoantibodies present in sera of patients with SLE, those binding DNA are 
of paramount interest, as the relationship is seen in many SLE patients, between 
levels of anti-dsDNA antibodies and clinical activity. The elution of these 
antibodies from the kidney of lupus patients and lupus prone mouse models, 
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and the fact that although antibodies to single stranded DNA are frequently 
found in the relatives of lupus patients, those binding double stranded DNA 
are virtually never detected. There are reports of serum anti-dsDNA antibody 
levels correlating with the severity of renal disease in SLE (Wallace et al., 
1993). Most large cohort of studies have tended to confirm that in the majority 
of cases, anti-dsDNA antibodies are linked most closely to the occurrence and 
severity of renal involvement (Swaak et al., 1979). Lloyd and Schur (1981) 
found that complement deposition and raised anti-dsDNA antibodies were 
associated more closely with renal than non-renal exacerbation in lupus. Active 
lupus nephritis was found to be associated with high anti-dsDNA antibody titre 
(Weisbart et al., 1990). More recently, Okamura et al., (1993) demonstrated 
a close relationship between renal disease activity assessed on biopsy, with 
IgG anti-dsDNA levels, but not with IgM anti-dsDNA or antibodies to single 
stranded DNA of either isotype. Various serological findings suggest that lupus 
nephritis results from the deposition of DNA-anti-DNA complexes and 
subsequent complement mediated tissue damage (Emlen et al., 1986; Pisetsky, 
1992; Zouali, 1997; Nishiya and Hashimoto, 1997). Eluted immunoglobulins 
from the kidney of female MRL-lpr/lpr mice with early nephritis was 
predominantly IgG with antibody activity against DNA. These eluted antibodies 
are also found to be reactive with multiple nucleic antigens and non-nucleic 
antigens like cardiolipin, suggesting that polyreactivity might be a distinguishing 
feature of nephritogenic autoantibodies. 
Healthy individuals, notably the elderly and especially relatives of patients 
with autoimmune disease may develop a range of autoantibodies without any 
diverse effect (Shoenfeld and Isenberg, 1989). In normal individuals, 
approximately 1-5% of B cells can produce antibodies against ssDNA with 
lower avidity which belongs to the IgM class (Guilbert et al., 1982; 1985). 
These antibodies can be elicited by non-specific polyclonal B cell activators, 
but not by the stimulation of DNA itself (Pisetsky and Caster, 1982). 
To explain the presence of anti-DNA antibodies in healthy individuals, it 
was also proposed that antibodies that are highly specific for bacterial DNA 
arise as part of the overall host response to infections by these organisms. 
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Bacterial DNA would be recognized as foreign because of the presence of 
sequence arrays, structural features, or higher ordered conformations that are 
not usually present in human DNA. 
An enormous amount of information about the anti-DNA antibodies has 
been assembled so far. It was found that anti-DNA antibodies serve an 
important role in normal immunity (as reflected by a high precursor frequency 
and use of germline encoded amino acid sequences), not because they bind 
DNA, but because they are polyspecific and can bind non-DNA antigens 
especially bacterial products (Pisetsky and Caster, 1982; Cairns et al., 1984, 
Klinman and Steinberg, 1987, Hoch and Schwaber, 1987). These antibodies 
are also found to be mutated into high affinity antibodies that bind more 
exclusively to foreign antigenic determinants (Neparstek et al., 1986). 
However, the DNA binding activity of these antibodies would be consequential 
under normal circumstances. In the SLE disease state, the DNA binding activity 
of these antibodies may also be of secondary importance, since this response 
may arise without direct involvement of DNA. Thus, anti-DNA antibodies may 
be induced non-specifically by polyclonal B cell activators or by generalized 
immunoregulatory disturbances among B and/or T cells (Smith and Steinberg, 
1983). Alternatively, a non-DNA self or foreign antigen may stimulate anti-DNA 
antibody production through an antigen specific mechanism. In these scenarios, 
polyspecificity represents an important property of these antibodies, which in 
the pathologic setting, leads to cross reactive anti-self responses. 
The direct involvement of anti-dsDNA antibodies in the pathogenesis of 
murine lupus has been recently re-examined. Murine monoclonal anti-dsDNA 
antibodies derived from MRL-lpr/lpr and SNF1 lupus prone mouse strains and 
injected into healthy strain mice are found to form immune deposits at distinct 
glomerular and vascular sites (Vlahakos et al., 1992a). Work of Schmeideke 
et al. (1989) showed that histones bind with high affinity to glomerular 
basement membrane (GBM), and anti-DNA antibodies bind to glomerulus via 
complexes of histones and DNA and to a lesser extent via DNA alone. In 
another study, Vlahakos et al. (1992b) have shown that murine monoclonal 
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antibodies were able to penetrate cells in vivo and, therefore, sufficiently with 
their normal function so as to contribute to their pathologic abnormalities. 
However, a very small percentage (5 out of 30) of these antibodies were able 
to do this, which suggest that direct anti-DNA antibody penetration is unlikely 
to be a significant pathologic process in SLE patients. 
Several genetic and environmental factors may play an important role in 
assessing the role of anti-DNA antibodies (Isenberg, 1997; Schwartz, 1997). 
In other studies of murine lupus, it was found that the primary mechanism of 
autoimmunity in the MRL models lies in the MRL/++ background; the Ipr genes 
act by accelerating and increasing the severity of the disease. As in the case 
of human disease, it is possible that while all strains produce anti-DNA, only 
the MRL-lpr/lpr produce a pathogenic variety. In MRL-lpr/lpr mice the gene 
is linked to the development and progressive SLE-like autoantibody formation 
(Cohen and Eisenberg, 1991). The defects in Fas mediated apoptotic pathway 
in autoimmune prone mice suggested that deletion of autoreactive T cells (Cohen 
and Eisenberg, 1992) may, in part, be responsible for the autoimmune 
syndrome. Recently, a relationship between defective Fas mediated apoptosis 
and autoimmunity in the MRL/Ipr mouse was investigated (Emlin et al., 1994; 
Nagata and Suda, 1995). In MRL/lpr mice, failure of apoptosis of CD4+ cells 
in the periphery of the thymus allows self reactive T cells to persist and 
ultimately drive autoantibody production by B cells (Steinberg, 1994). 
Thus, no single mechanism can fully explain the origin of human lupus in 
general, or anti-dsDNA antibodies, in particular. From the various experiments 
performed, the main concept that emerged on the origin of human lupus is that, 
the systemic autoimmune disease is the result of polyclonal B cell activation 
(Klinman and Steinberg, 1987) and that auto-reactive clones are the result of 
antigen driven specific stimulation (Hardin, 1986). Last, but not the least, one 
envisages a two stage development, incorporating elements of both polyclonal 
activation and an antigen driven response (Zouali, 1992). Based on the evidence 
available from human studies, the third view is considered to be the most valid 
explanation (Isenberg et al., 1994). 
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Mammalian DNA is non-immunogenic in a variety of animal species tested 
(Schwartz and Stollar, 1985), whereas, bacterial DNA is able to induce a strong 
antibody response in mice (Gilkeson et al., 1989). It has been noted that anti-
DNA antibodies may be structurally very similar to anti-bacterial antibodies 
(Hahn and Tsao, 1993). Rekvig et al. (1995), exploring the reaction to polyoma 
virus BK, have found that infection to this virus into young lupus prone mice, 
prior to the natural onset of the disease induced a strong persistent anti-dsDNA 
response more typical of lupus patients (Fredrikson et al., 1994). This suggests 
that anti-dsDNA might arise from stimulation with foreign, rather than self DNA. 
Monoclonal antibodies raised against a complex of native DNA and synthetic 
DNA binding protein shared DNA specificities and V region structure with anti-
DNA monoclonal derived from lupus prone NZB/NZW mice (Krishnan and 
Marion, 1993). It was thus hypothesized that the likely stimulus to anti-DNA 
antibody production is the possibility that nucleosome material i.e. DNA-linked 
to histone is the key immunogen (Ehrenstein et al., 1993). Blount et al. (1989) 
postulated that DNA damaged by ROS may effect the development of 
autoimmune diseases, such as SLE. It has been suggested that activated 
phagocytic cells capable of releasing ROS could penetrate cell membranes, 
interact with nuclear DNA causing the release of altered DNA, inturn stimulating 
anti-DNA antibody production (Gordon et al., 1990; Alam et al., 1993). The 
hypothesis that ROS modification of DNA is involved in the development of 
autoantibodies in SLE has been supported by the enhanced reactivity of SLE 
anti-DNA antibodies to ROS-modified DNA (Blount et al., 1990; Ara and Ali, 
1993). 
Anti-DNA antibodies are polyspecific showing enormous cross reactivity. 
However, a range of specificities to these antibodies, monoclonal antibodies 
and sera from SLE patients and lupus prone animal models show that reactivity 
may be greater towards denatured forms of DNA (Stollar et al., 1986). Anti-
DNA antibodies are found to react with poly(dA-dT), poly(dG-dC), poly(dA), 
poly(dT), poly-d(BrU) (Tron et al., 1980; Gripenberg et al., 1981; Hahn and 
Ebling, 1984; Gibson et al., 1985; Stollar et al., 1986). Antibodies reacting 
with natural ribonucleic acids, both double stranded and single stranded, have 
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also been described in SLE sera. Reactivity with single stranded homopolymers 
poly(I), poly(A), poly(G) and poly(U) was also observed (Alarcon Segovia and 
Fishbein, 1975). 
Additional specificities include other forms such as RNA-DNA hybrid, 
triple helical RNA (Karonous et al., 1988), poly(A). poly(U) and 
poly(I).poly(C). Multiple conformations of DNA are also found to be 
recognized by SLE autoantibodies. For example, left handed DNA/Z-DNA, 
DNA-psoralen photoadduct, DNA-lysine photoadduct, hydroxyl radical 
modified DNA, estradiol-albumin-DNA conjugate and DNA-8-methoxypsoralen 
photoadduct (Hasan and Ali, 1990; Sehgal and Ali, 1990; Ali et al., 1991; 
Hasan et al., 1991; Alam and Ali, 1992; Alam et al., 1992; Ara et al., 1992; 
Ara and Ali, 1992; 1993; Arjumand and Ali, 1994; Moinuddin and Ali, 1994). 
ROS in SLE 
Reactive oxygen species (ROS) are important to life through both their 
beneficial and detrimental effects (Fuchs, 1993). Their involvement in conditions 
such as xenobiotic metabolism, hypoxia, ischemia and reperfusion is well 
documented (Fuchs, 1992), and may result in oxidative stress. Due to the ability 
of ROS to modify cellular components, including DNA, their role and 
importance in a variety of pathological conditions (Blake and Winyard, 1995) 
such as inflammation, carcinogenesis (Frenkel, 1992), aging, autoimmunity 
(Lunec et al., 1994) and degenerative conditions (Halliwell, 1989; 1994) is 
becoming increasingly clear. 
It has been shown that modification of DNA renders it more immunogenic 
(Hasan and Ali, 1990; Arjumand and Ali, 1994). Native DNA has been reported 
to be a weak immunogen and yet in certain pathological conditions for example, 
in the autoimmune disease, SLE, autoantibodies to multiple nuclear antigens 
including DNA and histones are formed. Blount et al. (1991) postulated that 
DNA damaged by ROS may effect the development of autoimmune diseases 
such as SLE. The process by which DNA is damaged in chronic inflammatory 
diseases may involve the release of ROS intermediates and their reaction with 
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DNA. It has been postulated that DNA damaged by ROS may result from 
perpetual stimulation of phagocytic cells by bacterial and immunological stimuli 
activating the membrane bound NADPH oxidase and releasing reactive oxygen 
species (Lunec et al., 1987). In some diseased states, the inflammatory process 
and thus the production of ROS may be amplified in the confined space of 
certain tissues. A further study, using UVC/H202 to produce ROS-modified 
DNA and polynucleotide antigens, showed not only high antigenic recognition 
by SLE sera (Ahmad et al., 1997), but also high immunogenicity following 
modification (Ara and Ali, 1993). Solar UV radiations have been shown to 
induce alterations in cellular DNA by mechanisms that include ROS production. 
UV photosensitivity is a common clinical feature of SLE. Sunlight may 
precipitate cutaneous LE or aggravate systemic LE (Morison, 1983) and the 
spectrum for reactivity has been shown to be in the range of 230-320 nm 
(Gilham, 1987). It is pertinent, therefore, to postulate that photoadduct 
formation or radical modification of DNA, alongwith immune modulation 
(Vermeer and Hurks, 1994) are factors either in the induction or exacerbation 
of an autoimmune response in SLE. The ubiquitous nature of free radicals may 
account for the range of possible etiological factors in SLE, such as UV and 
pharmacological agents through a common mechanism of action. 
8-hydroxyguanosine (8-OH-G) is a specific marker of oxidative damage 
to DNA. SLE cells are found to be more susceptible to oxidative stress on 
the basis of viability count. In addition, both normal and SLE cells exposed 
to H202 showed a rapid conversion of dG to 8-OH-G suggesting that there 
is an equal susceptibility to damage. However, whilst normal cells show a partial 
removal of the damaged mutagenic base from the DNA paralled by an increase 
of the base in the supernatant, SLE cells show a considerable decrease in the 
rate of removal, suggesting an impaired ability to excise 8-OH-G from DNA, 
which would inturn contribute to the increase in the number of cells dying 
(Lunec et al., 1994). These in vitro results are consistent with the in vivo 
data on the excretion of 8-OH-G in urine of SLE patients (Compton et al., 
1984). The hypothesis that ROS-modification of DNA is involved in the 
development of autoantibodies in SLE has been supported by the enhanced 
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reactivity of SLE anti-DNA antibodies to ROS-modified DNA (Blount et al., 
1989; 1990; Cooke et al., 1997). ROS modification exposes base residues 
in the DNA backbone and minor regions of ssDNA (Blount et al., 1994). It 
was observed by the same group that ROS-modification of human DNA 
produces a non-discriminating antigen for the diagnosis of SLE. ROS-DNA may, 
therefore, play a significant role in the generation of immune complexes which 
are of recognized importance in the pathogenesis of SLE (Lunec et al., 1994; 
Lisitsyna et al., 1996; Cooke et al., 1997). 
Poly-Inosinic Acid 
Originally, the structure of polynucleotides was investigated for the direct 
evidence they could provide regarding the structure of RNA. These 
polynucleotide systems have proved to have considerable interest in themselves 
with a variety of hydrogen bonded arrangements of the bases and have provided 
physico-chemical information regarding the factors contributing to the stability 
of nucleic acid structures in general. 
X-ray diffraction analysis of oriented and partially crystalline fibres of 
poly-inosinic acid [poly(I)] has resulted in new molecular model. An earlier 
fibre-diffraction study of poly(I) (Rich, 1958) led to the conclusion that the 
ordered molecular structure was probably a triple-stranded, right-handed helix. 
A four stranded helix was considered and rejected partly because its diameter 
was thought to be too large. Later, Thiele and Guschibauer (1973) reviewed 
the results of many physical and immunological experiments and concluded that 
the ordered form of poly(I) is probably a four-stranded, left-handed helical 
structure. Later, Zimmerman et al. (1975) favoured this structure. The four-
stranded structure of poly(I) is different from the previously described nucleic 
acid structures. Although, all other RNA structures belong to the A family with 
C-3 endofuranose ring, it is remarkable that poly(I) is like B-DNA with C-
2 endofuranose rings. The stereochemistry of poly(I) revealed that there may 
be additional hydrogen bonds within individual chains. Every ribose hydroxyl 
group could form a hydrogen bond of 0.25 nm length with a phosphate oxygen 
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atom 0-3 in the preceeding (the angle C-2-0-6 0-3 is 101°). Generally, 
in RNA helices, with C-3 endo-sugar rings, this free hydroxyl group sticks out 
to form inter molecular hydrogen bonds (Arnott et al., 1966). However, the 
centre to centre distance between neighbouring molecules of poly(I) is 2.79 
nm, nearly 0.33 nm greater than the molecular diameter. There are, therefore, 
no interactions between neighbouring molecules except through the water and 
cations in the intervening space. 
The presence of metal ions has been shown to be essential for the 
formation of the four-stranded helical complex of poly(I), the stabilizing effect 
of these ions being related to their ability to fill effectively the central hole 
of the tetrameric basic units (Miles and Frazier, 1978; Howard and Miles, 
1982). Studies conducted by Simard and Savoie (1994), have shown that 
Raman spectra of poly(I) in H20 and D20 solutions at 10°C and 80°C, are 
in general agreement with those of earlier studies (Brown et al., 1972; Small 
and Pelicolas, 1971; Chou et al., 1977). They have also shown that the spectral 
changes resulting from self-association in poly(I) can be readily determined by 
comparing the results at 80°C, where the biopolymer exsists as a single-
stranded disordered macromolecule with those at 10°C, at which temperature 
poly(I) is self-associated into right-handed quadruple helix. 
Antigenicity of RNA 
It is well established that double-stranded synthetic polyribonucleotides 
adsorbed on methylated bovine serum albumin (MBSA) are capable of eliciting 
an immune response in rabbits (Nahon-Merlin et al., 1973). Several reports 
have also described successful immunization with RNA preparations. Lamon and 
Bennett (1970) immunized rabbits with yeast RNA and obtained sera that 
precipitated in gel with yeast, human, rabbit and rat RNA, but not with mouse 
RNA. Another approach in attempts to immunize free nucleic acids has been 
the use of animals having a genetic predisposition to the spontaneous production 
of such antibodies. Injection of denatured DNA (Lambert and Dixon, 1968) 
or of double-helical polyribonucleotide, poly(I).poly(C) (Carpenter et al., 
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1970) into NZB/NZW mice accelerated spontaneous production of antibodies 
to DNA and to dsRNA. With the double stranded polyribonucleotides, neither 
carrier nor specific genetic predisposition is required for a response. Steinberg 
et al. (1969, 1971) found that NZB/NZW mice did respond to poly(I).poly(C) 
without carrier or adjuvant. Other strains responded to poly(I).poly(C) given 
with adjuvant, but without carrier, by forming antibodies to dsRNA forms 
(Steinberg et al., 1971; Thoburn et al., 1971; Bonavida and Fuchs, 1972). 
Ribosomes of bacterial (Barbu et al., 1959) or mammalian (Lacour et al., 
1962) origin when used as immunogen, showed different kind of specificity for 
nucleic acids. The resulting sera contained two kinds of antibodies, those that 
are species specific and are directed against ribosomal proteins and those which 
reacted with ribosomes from any source and were probably directed against 
RNA. 
It has been found that sera of rabbits immunized with poly(I).poly(C)-
MBSA complex precipitate not only poly(I).poly(C) but also poly(I) (Negro-
Pouzi et al., 1971; Field et al., 1972; Nahon-Merlin et al., 1973). Guiges 
and Leng (1976) have shown that in these sera, three families of antibodies 
are found reacting specifically with poly(I).poly(C), poly(I) and poly(C), 
respectively. 
Many anti-nucleic acid antibodies are found in the sera of patients with 
SLE (Munns and Liszewski, 1980; Casperson and Voss, 1983; Stollar, 1986) 
and in related diseases in animals. As native DNA (nDNA) has not been an 
effective immunogen in experimental animals, the autoimmune subjects are the 
primary source of antibodies that react with DNA. Monoclonal representatives 
of anti-DNA antibodies have been studied extensively (Stollar, 1986). Most 
react much more strongly with denatured DNA than with nDNA. Their reactions 
with synthetic polynucleotides were also studied (Stollar et al., 1986; Ali et 
al., 1985). The monoclonal antibody (Mab) H241 produced by a hybridoma 
was derived from MRL-lpr/lpr lupus mouse strain. Both poly(G) and poly(I) 
were found to react with H241 and poly(I) was the more strongly reactive. 
It was suggested on the basis of its reactivity with guanine and hypoxanthine, 
26 
but not adenine containing polymer that 6, 7 and 8 positions of the purine 
exposed in the major groove, would likely be involved. 
The existence of autoantibodies specifically reactive with sequences and 
structures in RNA molecules was demonstrated by Wilusz and Keene (1986) 
using U1RNA and certain transfer RNAs. The finding that certain RNA 
sequences can react specifically with autoantibodies provided a clue that 
autoimmune recognition might involve interactions with conformational three 
dimensional epitopes in RNA (Deutscher and Keene, 1988). Hoet et al. (1992) 
have presented evidence that sequence specificity was not evidence that anti-
U1RNA autoantibodies correlate with the severity of the disease in a manner 
similar to that of anti-DNA. Although the molecular origins of anti-DNA 
antibodies have remained enigmatic, it is possible that DNA is not the authentic 
autoantigen, but represents a cross-reactive immunological event. Experiments 
to date have not demonstrated that specific sequences are recognized by anti-
DNA antibodies, although certain bacterial DNA show preferred reactivity with 
autoantibodies (Pisetsky et al., 1995). The demonstration that conformation-
specific RNA epitopes can be recognized by autoantibodies makes it difficult 
to understand how direct presentation alone can explain the origin of anti-RNA 
antibodies (Deutscher and Keene, 1988; Keene, 1996). Although the precise 
molecular mechanism accounting for the origin of nucleic acid reactive 
autoantibodies remain obscure, it has been suggested that some conformational 
nucleic acid epitopes may be cross-reactive with proteinaceous autoantigens 
and that such molecular mimicry may be responsible for the production of anti-
RNA antibodies (Keene, 1996). 
Objective of the Present Study 
SLE is an autoimmune disease characterized by a broad diversity of 
clinical features and serum autoantibodies. The etiopathogenesis is 
multifactorial. The mechanisms, however, whereby these autoantibodies are 
triggered remain elusive. A population of anti-DNA autoantibodies is present 
in the serum of SLE patients and their titres correlate with disease activity. 
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Reactive oxygen species (ROS) are implicated in the inflammatory autoimmune 
diseases such as SLE, particularly with respect to processes leading to the 
formation of pathological anti-DNA antibodies. 
In the present study, a synthetic ribohomopolymer, poly(I) was modified 
with hydroxyl radical. The native and ROS modified poly(I) were characterized 
by UV spectroscopy, thermal denaturation studies, agarose gel electrophoresis, 
Sephadex G-200 chromatography and densitometric scanning. DEAE Sephadex 
A-25 chromatography was used to quantify base modification in poly(I). The 
antigenicity of both native and modified poly(I) was evaluated. Both native and 
modified poly(I) was used to generate antibodies in rabbits. The raised 
antibodies were characterized for their fine antigenic specificity. The possibility 
of ROS-modified poly(I) being the immunogenic trigger for the production of 
anti-DNA antibodies in SLE was probed. Sera from SLE patients were 
investigated for the presence of antibodies to native and ROS-modified poly(I). 
Counterimmunoelectrophoresis was also performed to detect the presence of 
precipitating antibodies to native and ROS-poly(I) in SLE sera. Moreover, 
antibodies against native and ROS-poly(I) were also raised in rats and the 
immune complex deposition in the kidney glomeruli of rats were detected by 
immunofluorescence. 
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MATERIALS 
Polyinosinic acid [poly(I)], other synthetic polynucleotides, DEAE-
Sephadex A25, Protein A-Sepharose CL-4B, Ficoll 400 and agarose were 
purchased from Pharmacia Fine Chemicals, Sweden. Calf thymus DNA, buffalo 
thymus RNA, micrococcal nuclease, nuclease SI , bovine serum albumin, 
methylated bovine serum albumin, anti-human, anti-rabbit-IgG-alkaline 
phosphatase conjugates, anti-rat-IgG-HRP conjugate, Coomassie Brilliant Blue 
G250 and R250, sodium dodecyl sulphate, Tween-20, ethidium bromide, 
Freund's complete and incomplete adjuvants, Millipore filter (0.45 um pore size), 
lambda DNA Eco RI and Hind III digest were obtained from Sigma Chemical 
Company, U.S.A. Folin-Ciocalteau reagent and p-nitrophenyl phosphate were 
purchased from Centre for Biochemical Technology, New Delhi. 
Polystyrene microtitre flat bottom ELISA plates having 96 wells (7 mm 
diameter) were purchased from Nunc, Denmark. Acrylamide, bisacrylamide, 
ammonium persulphate, N,N,N',N'-tetramethylethylene diamine (TEMED) were 
from Bio-Rad Laboratories, U.S.A. EDTA (disodium salt), hydrogen peroxide, 
isoamyl alcohol, chloroform were from Qualigens, India. Diphenylamine, orcinol 
and ethanol were chemically pure. All other chemicals were of highest analytical 
grade available. 
Equipment 
ELISA microplate reader MR-600 (Dynatech, U.S.A.), ELISA microplate 
washer (Denley, England), Elico pH meter model Ll-120, Shimadzu UV-240 
spectrophotometer equipped with thermo-programmer and controller unit, gel 
scanner GSC-3A, ultraviolet lamp having maximum emission at 253.4 nm (Vilber 
Lourmat, France), Avanti 30 table top high speed centrifuge (Beckman, U.S.A.), 
Polyacrylamide gel electrophoresis assembly (Bio-Rad, U.S.A.), UV trans-
illuminator (Vilber Lourmat, France), Agarose gel electrophoresis assembly 
GNA-100 (Pharmacia, Sweden), Beckman ultracentrifuge were the major 
equipments used in this study. 
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Sera Specimen 
Sera were obtained from outdoor and indoor patients of the Department 
of Medicine, All India Institute of Medical Sciences, New Delhi and J.N. Medical 
College Hospital, A.M.U., Aligarh. The SLE sera collected showed high titre 
anti-DNA antibodies and fulfilled the American College of Rheumatology criteria 
for the diagnosis of SLE (Arnett et al., 1988). Normal human sera were obtained 
from healthy individuals and stored in small aliquots at -20°C. Complement was 
inactivated by heating at 56°C for 30 min before use. 
METHODS 
Purification of DNA 
Commercially available, highly polymerized calf thymus DNA was purified 
free of proteins and single stranded regions (Ali et al.,1985). DNA was 
dissolved in 0.1 x SSC (15 mM sodium citrate and 150 mM sodium chloride), 
pH 7.3. Solution of DNA (2 mg/ml) was then mixed with equal volume of 
chloroform-isoamyl alcohol (24:1) in a stoppered cylinder and shaken for 1 hr. 
The DNA present in the aqueous layer was separated from the organic layer and 
re-extracted with chloroform-isoamyl alcohol. The DNA was precipitated with 
two volumes of cold 95% ethanol and collected on a glass rod. Traces of water 
was removed by rinsing the rod with ethanol, and dried by pressing against the 
wall of the container. The DNA was then dissolved in 30 mM acetate buffer, pH 
5.0 containing 30 mM zinc chloride and treated with nuclease SI (150 units/mg 
DNA) at 37°C for 30 min to remove single stranded regions. The reaction was 
terminated by adding one-tenth volume 200 mM EDTA, pH 8.0. The purified 
DNA was extracted twice with chloroform-isoamyl-alcohol and finally 
precipitated with 95% ethanol. The precipitate was dissolved in PBS (10 mM 
sodium-phosphate, containing 150 mM NaCl ), pH 7.4. 
Estimation of DNA by Diphenylamine 
Colorimetric estimation of DNA was carried out by the method of Burton 
(1956) using diphenylamine reagent. 
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(a) Preparation of diphenylamine reagent 
Recrystallized diphenylamine (750 mg) was dissolved in 50 ml of glacial 
acetic acid containing 0.75 ml concentrated sulphuric acid. The reagent was 
prepared immediately before use. 
(b) Procedure 
To varying amounts of DNA in 1.0 ml, 1.0 ml of IN perchloric acid was 
mixed and incubated at 70°C in water bath for 15 min. One hundred uL of 5.43 
mM acetaldehyde was added followed by 2.0 ml of diphenylamine reagent. The 
contents were mixed and allowed to stand at room temperature for 16-20 hr. 
Absorbance was read at 600 nm and the concentration of DNA in unknown 
samples was determined from the standard plot of purified calf thymus DNA. 
Determination of RNA Concentration 
RNA was estimated by ferric ion catalysed orcinol reaction (Cerrioti, 1955). 
(a) Crystallization of orcinol 
Commercial orcinol (5 gm) was dissolved in 100 ml boiling benzene and 
decolorized with 1 gm of activated animal charcoal. The suspension was filtered 
while hot and kept at room temperature for 1 hr and at 4°C until crystallization 
was complete. The crystals were filtered and dried at room temperature. 
(b) Orcinol reagent 
(i) 100 mg ferric chloride was dissolved in 100 ml concentrated HC1. 
(ii) 6% (w/v) orcinol in distilled ethanol. 
The reagent was prepared fresh by mixing 3.5 ml of (ii) with 100 ml of (i) and 
used immediately. 
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(c) Procedure 
RNA solution was mixed with 3 ml of orcinol reagent and placed in boiling 
water for 30 min. The tubes were chilled in ice water and absorbance was read 
at 665 nm. Concentration of unknown samples were calculated from standard plot 
of buffalo thymus RNA. 
Estimation of Protein 
Protein was estimated by the methods of Lowry et al. (1951) and Bradford 
(1976). 
Protein Estimation by Folin's-Phenol Reagent 
The protein estimation by this method utilizes alkali (to maintain high pH), 
Cu2+ ions (to chelate proteins) and tartarate (to keep the Cu2+ ions at high pH). 
(a) Folin-Ciocalteau reagent 
The reagent was purchased from Centre for Biochemical Technology, New 
Delhi. It was diluted with distilled water in the ratio of 1:4 before use. 
(b) Alkaline copper reagent 
The components of alkaline copper reagent were 
(i) Two percent sodium carbonate in 100 mM sodium hydroxide 
(ii) 0.5 percent copper sulphate in 1.0% sodium potassium tartarate 
The working reagent was prepared fresh by mixing components (i) and (ii) 
in the ratio 50:1. 
(c) Procedure 
To 1.0 ml of protein sample was added 5 ml of alkaline copper reagent. 
The contents were mixed and allowed to stand at room temperature for 10 min. 
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One ml of working Folin-Ciocalteau reagent was added and after 30 min. 
absorbance was read at 660 nm. The concentration of unknown sample was 
determined from a standard plot of bovine serum albumin. 
Protein Estimation by Bradford Method 
This assay is based on colour change that occurs when Coomassie Brilliant 
Blue G250 in acidic solution, binds strongly to protein hydrophobically and at 
positively charged groups. In the environment of these positively charged groups, 
protonation is suppressed and a blue colour is observed ( Xmtx 595 nm). 
(a) Dye preparation 
Coomassie Brilliant Blue G250 (100 mg) was dissolved thoroughly in 50 ml 
of 95% ethanol. One hundred ml of 85% (v/v) orthophosphoric acid was added 
to this solution. The resulting solution was diluted to a final volume of 1 litre. 
On every use the dye solution was filtered, to remove undissolved particles. 
(b) Procedure 
Solutions containing 10-100 ng protein in a volume of up to 0.1 ml was 
pipetted into test tubes. The volume was adjusted to 1 ml with appropriate 
buffer. Five ml of dye solution was added and the contents were vortexed. The 
absorbance was read at 595 nm after 2 min and before 1 hr against a reagent 
blank prepared from 0.1 ml of buffer and 5.0 ml of dye solution. 
ROS Modification of Poly(I) 
Aqueous solution of native poly(I) (0.288 mM) in PBS, pH 7.4 were 
irradiated under 254 nm light for 60 min at room temperature in the presence of 
hydrogen peroxide. Excess of hydrogen peroxide after irradiation was removed 
by extensive dialysis against PBS, pH 7.4. Native poly(I) samples exposed to 
hydrogen peroxide or UV light alone were used as corresponding controls. 
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Spectroscopic Analysis 
The ultraviolet spectra of modified and unmodified poly(I) were recorded 
in the range of 200-400 nm on Shimadzu UV-240 spectrophotometer. 
Absorption-Temperature Scan 
Thermal denaturation analysis of nucleic acids was accomplished in order 
to ascertain the degree of modification incurred on the nucleic acids. On a 
Shimadzu UV-240 spectrophotometer coupled with a temperature programmer 
and controller assembly, native and modified poly(I) samples were subjected to 
heat denaturation (Hasan and Ali, 1990). Samples were melted from 30°C to 
95°C at a rate of 1.5°C/min after 10 min equilibration at 30°C. The change in 
absorbance at 248 nm was recorded with increasing temperature. Simultaneously, 
UV spectra were also recorded at 30°C and 95°C in the same wavelength range. 
Polyacrylamide Gel Electrophoresis 
Native and modified poly(I) were subjected to PAGE under non-denaturing 
conditions as described by Laemmli (1970). The following stock solutions were 
prepared. 
(i) Acrylamide-bisacrylamide (30:0.8) 
Thirty gm acrylamide and 0.8 gm bisacrylamide were dissolved in distilled 
water to a final volume of 100 ml. The solution was filtered and stored in an 
amber colored bottle to prevent photo-polymerization. 
(ii) Resolving gel buffer 
In 48 ml of 1 N HC1, 36 gm Tris was dissolved and pH adjusted to 8.8 and 
final volume made upto 100 ml with distilled water. 
(Hi) Stacking gel buffer 
Six gm Tris was dissolved in 40 ml distilled water, pH adjusted to 6.8 with 
1 N HC1 and final volume made upto 100 ml with distilled water. 
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(iv) Electrode buffer 
The electrophoretic buffer used was TAE, pH 7.9 (40 mM Tris, 1.14 ml 
glacial acetic acid and 1 mM EDTA). 
Procedure 
The PAGE apparatus was assembled and plates separated by 1.5 mm thick 
spacer were sealed with 1% agarose from the sides and bottom. The non-
denaturing gel was prepared and poured between the glass plates and allowed 
to polymerize at room temperature. Samples of poly(I) (5 ug) were mixed with 
one-tenth volume of stop mix (30% Ficoll, 0.025% Xylene Cyanole FF and 500 
mM EDTA in 10 times concentrated TAE buffer) and applied onto the gel. The 
gel was electrophoresed for 8-10 hr at 80 volts, stained with ethidium bromide 
(0.5 ug/ml) and visualized under UV light. 
Recipe for 7.5 % non-denaturing PAGE 
Acrylamide-bisacrylamide 10.0 ml 
Resolving gel buffer 5.0 ml 
1.5% Ammonium persulphate 1.5 ml 
Distilled water 23.5 ml 
TEMED 20.0 uL 
PAGE for Proteins 
A 7.5% resolving gel was layered with 2.5% stacking gel according to the 
following composition. 
Solutions 
Acrylamide-bisacrylamide 
Stacking gel buffer 
Resolving gel buffer 
Distilled water 
10% SDS 
1.5% Ammonium persulphate 
TEMED 
Stacking gel 
2.5 ml 
5.0 ml 
-
11.3 ml 
0.2 ml 
1.0 ml 
15 uL 
Resolving gel 
7.5 ml 
-
3.75 ml 
16.95 ml 
0.3 ml 
1.5 ml 
15 uL 
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Protein samples were mixed with one-fourth volume of sample buffer (10% 
glycerol and 0.002% bromophenol blue in 10 times concentrated 500 mM Tris 
HC1, pH 6.8) and applied onto the gel. Electrophoresis was performed at 70 
volts for 6-8 hr in Tris-glycine buffer (25 mM Tris, 192 mM glycine containing 
1% SDS), pH 8.3. The gels were stained overnight with 0.1% Coomassie Brilliant 
Blue R250 (in 25% isopropanol and 10% glacial acetic acid). A mixture of 10% 
methanol and 10% glacial acetic acid was used for destaining the gel. 
Detection of Single Strand Breaks 
Hydroxyl radical mediated damage to poly(I) was characterized by the 
presence of strand breaks. The presence of strand breaks was ascertained by 
Sephadex G-200 gel chromatography, densitometric scanning and agarose gel 
electrophoresis. 
(a) Sephadex G-200 gel chromatography 
Gel filtration was performed on Sephadex G-200 column. Five gm of gel 
was swollen in distilled water for 5 hr in a boiling water bath. The degassed gel 
slurry was poured into the column (1 cm x 42 cm) and left overnight at room 
temperature to settle under gravity. The flow rate was increased gradually and 
adjusted to 20 ml/hr. Uniform packing of column was checked by passing 0.2% 
(w/v) solution of Blue Dextran 2000. The column was equilibrated with PBS, pH 
7.4. 
One ml of native and ROS-poly(I) was applied onto the column. The sample 
was allowed to percolate through the upper surface of the gel. The column was 
connected to a reservoir containing equilibrating buffer. Fractions of 3 ml were 
collected and absorbance monitored at 248 nm. 
(b) Densitometric scanning 
Samples of native and ROS-poly(I) were subjected to polyacrylamide gel 
electrophoresis on 7.5% native gel. The stop mix dye added was without Xylene 
Cyanole FF. The 6 cm lanes, each of native and ROS-poly(I), were cut and 
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scanned on gel scanner GSC-3A of Shimadzu UV-240 spectrophotometer. Gel 
was scanned at the rate of 10 mm/min and the spectra were recorded 
simultaneously at a fixed wavelength of 248 nm. 
(c) Agarose gel electrophoresis 
One percent agarose in 30 ml TAE, pH 7.9 was dissolved by heating in 
boiling water bath. The solution was allowed to cool at 50°C and poured onto 
the gel tray and left at room temperature for complete solidification. Samples 
mixed with one-tenth volume of stop mix dye, were loaded in the wells of the 
submerged gel and electrophoresed for 2 hr at 30 mA. The gels were stained with 
methylene blue in 200 mM sodium acetate buffer, pH 4.7 and destained in tap 
water. 
(d) Gel diffusion 
Native and ROS-poly(I) were mixed with one-tenth volume of "stop mix" 
without Xylene Cyanole FF and electrophoresed on 1% agarose gel for 2 hr at 
30 mA. Lanes of native and ROS-poly(I) were cut separately. Each lane was 
further sliced into 5 mm pieces. Each slice was gently crushed in 0.2 ml of 10 
mM Tris-HCl buffer, pH 8.0 containing 150 mM NaCl (Maxam and Gilbert, 1980) 
in different microfuge tubes. After oyernight incubation at 37°C, the tubes were 
centrifuged at 10,000 rpm for 10 min. The supernatant containing poly(I) was 
filtered through millipore filter (0.45 \im) and read at 248 nm. 
Separation and Quantitation of Base Modification 
The separation and quantitation of hypoxanthine base in modified poly(I) 
was performed according to the method described by Hasan and Ali (1990). 
(a) Acid hydrolysis of poly (I) 
Native and modified poly(I) were precipitated with two volumes of cold 
ethanol and dissolved in 70% perchloric acid. The samples were heated for 1 hr 
at 100°C to release the bases. After neutralization, the hydrolyzate was 
chromatographed on DEAE-Sephadex A-25 matrix. 
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(b) DEAE-Sephadex A-2S column chromatography 
The swollen ion exchanger was mixed with starting buffer (1 mM Tris-HCl, 
pH 7.6) to form a fairly thick slurry. The suspension was poured in to the column 
and gel was allowed to settle. The column was equilibrated with ten volumes of 
buffer. Sample (3 ml) was loaded onto the column and eluted with a linear 
gradient of 1-20 mM Tris-HCl, pH 7.6 at a flow rate of 40 ml/hr. Fractions 
of 3 ml were collected and absorbance was recorded at 248 nm. Elution profile 
of standard hypoxanthine base and hydrolyzed native poly(I) served as controls. 
Immunization Schedule 
Female rabbits (8-12 months weight 1-1.5 kg) were immunized with native 
and ROS-modified poly(I). The immunizing antigen (50 fig/rabbit) was mixed with 
methylated bovine serum albumin (MBSA) in the ratio of 1:1 (w/w) and emulsified 
with equal volume of Freund's complete adjuvant (FCA) for the first injection 
given subcutaneously at multiple sites. Subsequent injections were given in 
incomplete Freund's adjuvant (IFA) intramuscularly. Each animal received a total 
of 300 ng of antigen during the course of six injections. Booster dose was 
administered after a fortnight from the last injection. Blood was collected by 
cardiac puncture and serum separated. The separated serum was 
decomplemented by heating at 56°C for 30 min. Preimmune sera were collected 
before immunization. The sera were stored in small aliquots at -80°C with 0.1% 
sodium azide as preservatives. Animals were sacrificed and organs stored at -
80°C for immunofluorescence. 
Isolation of IgG by Protein A-Sepharose CL-4B 
Serum IgG was isolated by affinity chromatography on Protein A-Sepharose 
CL-4B column. 0.5 ml serum diluted with equal volume of PBS, pH 7.4 was 
applied to column (0.9 cm x 15 cm) equilibrated with the same buffer. The 
washthrough was recycled 2-3 times. Unbound IgG was removed by extensive 
washing with PBS, pH 7.4. The bound IgG was eluted with 0.58% acetic acid 
in 0.85% sodium chloride (Goding, 1976) and neutralized with 1 ml of 1 M Tris-
HCl, pH 8.5. Three ml fractions were collected and read at 280 nm 
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and concentration was determined considering 1.4 O.D2g0 = 1.0 mg IgG/ml. 
The IgG was then dialyzed against PBS, pH 7.4 and stored at -20°C with 0.1% 
sodium azide. 
Immunological Techniques 
Immune sera and SLE sera were tested for antibodies by immunodiffusion, 
counterimmunoelectrophoresis, enzyme linked immunosorbent assay and gel 
retardation assay. 
(a) Immunodiffusion 
Immunodiffusion (ID) was carried out by Ouchterlony double 
immunodiffusion system using glass petri dishes as described by Tan et al. 
(1966). Six ml of 0.4% molten agarose in PBS, pH 7.4 containing 0.1% sodium 
azide poured onto glass petri dishes and allowed to solidify at room temperature 
and then kept at 4°C for 4 hr. Wells 5 mm in diameter separated by 8 mm 
in distance were cut into hardened gel. Antigen and antibody were loaded and 
kept in moist chamber for 24-48 hr. The petri dishes were washed with 5% 
sodium citrate to remove non-specific precipitin lines if any. The precipitin lines, 
were analyzed visually and photographed. 
(b) Counterimmunoelectrophoresis 
Counterimmunoelectrophoresis was performed by the method of Kurata and 
Tan (1976). Molten agarose 0.6% in 25 mM barbital buffer, pH 8.4 containing 
0.1% sodium azide was poured onto 2.5 mm thick glass slides (7.5 cm x 2.5 cm) 
and allowed to harden at room temperature and then at 4°C. Wells each 3 mm 
in diameter were cut and loaded with antigen and antibodies (in anodal and 
cathodal wells respectively). The slides were then electrophoresed for 45-60 min 
in 50 mM barbital buffer, pH 8.4 with a current of 3-4 mA per slide. Non-specific 
precipitin lines were removed with 5% sodium citrate. 
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gfln-antibody interaction was visually detected by gel retardation assay 
al., 1988). A constant amount of nucleic acid samples were 
ith varying amounts of IgG in PBS, pH 7.4 for 2 hr at 37CC and 
4°C. One-tenth volume of "stop mix" dye was added to the mixture. 
dresis was performed on 0.8% agarose for 2 hr at 30 mA in TAE 
7.9. The gels were stained with 0.2% methylene blue in 200 mM 
tate buffer, pH 4.7 and destained by continous running water. 
(d) Enzyi le linked immunosorbent assay (ELISA) 
ELISJ v was performed using polystyrene (96 wells) flat bottom microtitre 
plates as c escribed by Aotsuka et al. (1979). 
(i) Buffer and substrate 
Tris buffeted saline (TBS) 
10 mil Tris, 150 mM sodium chloride, pH 7.4. 
Tris buffeted saline-Tween 20 (TBS-T) 
20 ml|[ Tris, 144 mM sodium chloride, 2.68 mM potassium chloride (KC1), 
pH 7.4, containing 500 uL Tween-20/L 
Carbonate\bicarbonate buffer 
15 mil sodium carbonate, 35 mM sodium bicarbonate, 2mM magnesium 
chloride, iH 9.6. 
Citrate-phosphate buffer 
22 m] i citric acid, 50 mM disodium hydrogen phosphate, pH 5.0 
Substrata 
40 
(i) 500 ug p-nitrophenyl phosphate (p-NPP)/ml of carbonate-bicarbonate 
buffer. 
(ii) 500 ug o-phenylenediamine (OPD)/ml citrate- phosphate buffer, 
containing 1 ul/mL of hydrogen peroxide. 
(ii) Procedure 
Polystyrene microtitre plates were coated with 100 uL of antigen (2.5 ug/ 
ml in TBS, pH 7.4) for 2 hr at room temperature and overnight at 4°C. Unbound 
antigen was removed by washing thrice with TBS-T. Unoccupied sites were 
blocked with 150 uL of 1.5% BSA in TBS for 4-6 hr at room temperature. The 
plates were washed once with TBS-T. The antibody (100 uL well) to be tested, 
diluted in TBS was coated in each well. After incubating the plates for 2 hr at 
room temperature and at 4°C overnight, the plate was extensively washed with 
TBS-T. The bound antibodies were then assayed by an appropriate anti-
immunoglobulin alkaline phosphatase or horse radish peroxidase conjugate using 
p-nitrophenyl phosphate or the OPD/H202 substrate, respectively. The plates 
were incubated at 37°C for 1 hr and the reaction was stopped in the case of 
OPD/H202 system with 50 uL of 5 N H2S04 and then read at 490 nm. Each 
sample was coated in duplicate and the results were expressed as a mean of Atest 
- A , ,. 
control 
Competition ELISA 
The antibody specificity was determined by competition ELISA (Hasan et 
al., 1991). Varying amounts of inhibitors (0-20 ug/ml) were incubated with a 
constant amount of antibody for 2 hr at room temperature and overnight at 4°C. 
The resulting immune complex was coated in wells instead of the serum. The 
remaining steps were the same as it was in direct binding ELISA. The results were 
expressed as percent inhibition. 
A 
inhibited 
% inhibition = 1 X 100 
A 
uninhibited 
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Quantitative Precipitin Titration 
The antigen-antibody interaction was also investigated by performing 
precipitin analysis under equilibrium conditions. To a series of eppendorff tubes, 
each containing 100 ug of IgG, increasing amounts of antigen (0-40 ug) were 
added, in an assay volume of 0.2 ml. The mixture was incubated at 37°C for 2 
hr and overnight at 4°C. The tubes were centrifuged at 8,000 rpm for 2 min. The 
precipitate was separated, washed three times with cold PBS, pH 7.4 and 
dissolved in a fixed volume of 1 M NaCl. The amount of bound and unbound 
antigen and antibody in the dissociated immune complex or supernatant was 
determined colorimetrically. For antigen, orcinol reagent (Ceriotti, 1955) and for 
antibody, dye binding method (Bradford, 1976) was used. The binding data was 
analyzed and antibody affinity was calculated (Langmuir, 1918). 
Detection of Immune Complexes Deposition in Kidney 
Kidneys from immunized rats were screened for detection of immune 
complexes deposition in glomeruli. 
(i) Immunization protocol 
Groups of four female rats (Sprague-Dawley), were immunized 
subcutaneously at multiple sites with native and ROS-poly(I) (50 ug/animal), 
complexed with methylated BSA (w/w) and emulsified in Freund's complete 
adjuvant. In control groups of rats, one group was immunized similarly, but 
without any antigen and another group served as control. The sera were screened 
for immune response by ELISA after decomplementing at 56°C. When necessary, 
another booster was given and finally the rats were sacrificed and kidneys stored 
at -80°C. 
(ii) Immunofluorescence 
Kidney sections (approx. 5 microns) were fixed on slides with acetone and 
incubated with anti-rat IgG fluorescein isothiocyanate conjugate (1:100 diluted) 
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for 30 min. Subsequently, slides were washed three times with PBS and mounted 
with 50% glycerol. The deposition of immune complexes was detected with 
fluorescence microscope. 
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ROS-Modification of Poly(I) 
Commercially available native poly(I), dissolved in PBS, pH 7.4 was 
modified with reactive oxygen species (ROS), generated by UV irradiation 
(253.7 nm) in the presence of hydrogen peroxide at different time intervals. The 
modified samples were dialyzed extensively against PBS, pH 7.4 to remove 
residual hydrogen peroxide. The UV spectra of poly(I) irradiated at different time 
intervals (10, 20, 30 and 60 min) were recorded. The spectra revealed an 
increase in hypochromicity with increase in time of irradiation. The maximum 
hypochromicity (47.8%) was observed in case of 60 minutes irradiated sample 
which was subsequently used for further studies . Poly (I) served as the 
corresponding control. The spectra are shown in figure 1. 
The perturbations incurred on poly(I) as a consequence of photochemical 
modification were also analysed by UV difference spectroscopical scanning (Fig. 
2). The spectral curve for native poly(I) with respect to buffer (PBS, pH 7.4) 
showed Xmax at 248 nm, characteristic of native poly(I). Difference spectrum 
of ROS-poly(I) with respect to native poly(I) revealed an appreciable negative 
inversion absorption in between 300-280 nm, followed by constant absorption. 
Native and ROS-poly(I) were mixed with poly(C) to form double stranded 
poly(I).poly(C) and ROS-poly(I).poly(C) complexes. The UV absorption 
characteristics of the native and ROS-modified poly(I) complexed with poly(C) 
are depicted in Table 1. The absorbance ratio A250/A260 for native poly(C) was 
0.86, for native poly(I) it was 1.6 and for ROS-poly(I) it was 1.4. On the 
formation of complex, the ratio changed to 0.93 in case of ROS-poly(I).poly(C), 
whereas, it became 1.13 in case of native poly(I).poly(C). The decrease in ratio, 
on formation of complex in case of ROS-poly(I).poly(C) is indicative of the 
formation of some modified species in the native conformer. 
Thermal Transition Studies 
The effect of thermal energy on the UV-spectral characteristics of native and 
modified poly(I) was assesed. UV- spectra were recorded at 30°C and 95°C 
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200 300 
WAVELENGTH ( n m ) 
Fig. 1. UV absorption characteristics of native and ROS-poly(I). Native poly(I) 
( ); native poly(I) irradiated in presence of H202 for 10 min 
( ); 20 min ( ); 30 min ( ); 60 min ( ). 
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Fig. 2. UV difference spectra of ROS-poly(I) (— 
Native poly(I) against buffer ( ) served as control. 
) over native poly(I). 
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TABLE 1 
UV Absorption Characteristics of Native and ROS-Poly(I) 
Complexed with Native Poly(C) 
Polymers Absorbance ratio (A /A ) 
Native poly(C) 0.86 
Native poly(I) 1.64 
ROS-poly(I) 1.42 
Poly(I).poly(C) 1.13 
ROS-poly(I).poly(C) 0.93 
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respectively, both for native and modified polymer. The UV-spectrum of native 
poly(I) at 95°C did not show any appreciable deviation from the spectral curve 
recorded at 30°C (Fig. 3). However, distinct hyperchromicity was observed in 
case of ROS-modified poly(I) at 95°C as compared to the spectrum at 30°C. 
(Fig.4). Surprisingly, ROS-modified poly(I) at 30°C exhibited similar UV-
spectral curves as observed for native poly(I) at 30°C and 95°C respectively. 
Thermodynamical Analysis of Modified and Unmodified 
Poly(I) 
The photochemical modification of synthetic nucleic acid homopolymer 
poly(I) was also investigated by means of thermodynamic analysis. The process 
was characterized by determining the change in the free energy of denaturation 
for both native and modified polymer. The increase in UV absorbance with 
change in temperature, at a rate of l°C/min. was taken as a measure of the extent 
of denaturation. 
When native poly(I) was heated from 30°C to 95°C, the free energy of 
denaturation (AGD) decreased linearly from 35°C (308.15°K) to 60°C 
(333.15°K). The AGD for native poly(I) was computed to be 2.174 K cal.deg" 
1
 at 308.15°K (35°C) and 1.279 K cal.deg"1 at 333.15°K (60°C). Further, 
supplementation of thermal energy above 333.15°K indicated a linear increase 
in the AGD values till 358.15°K (85°C). The AGD values as well as the 
appearance of only positive AGD which increased linearly till 333.15°K is 
indicative for the possibility that the thermal energy being implied on native 
poly(I) was encountering an opposition of low magnitude from the non-stable 
ionic bonds formed between the inosine base of one strand ionically linked to the 
backbone of the other strand. The thermodynamical results depicted in Table 2 
as well as in figure 5, are indicative for the non-base to base interaction in the 
tetrastranded poly(I). Furthermore, as evident from Table 2, elevation in 
temperature showed linear increase in the +AGD values above 333.15°K till 
358.15°K, which inturn is indicative of the transition of tetrastranded into four 
separate single stranded poly(I). In case of poly(I) subjected to ROS-
modification, the AGD value was computed to be 5.226 K cal. deg1 at 
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Fig. 3. UV absorption spectra of native poly(I) at 30°C ( ) and 95°C 
( )• 
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Fig. 4. UV absorption spectra of ROS-poly(I) at 30°C ( 
( )• 
) and 95°C 
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TABLE 2 
Thermodynamic Characteristics of Native and ROS-Modified Poly(I) 
Temperature 
(Absolute) 
308.15 
313.15 
318.15 
323.15 
328.15 
333.15 
338.15 
343.15 
348.15 
353.15 
358.15 
363.15 
368.15 
AGD in K. 
Native poly(I) 
2.174 
1.556 
1.351 
1.372 
1.260 
1.279 
1.436 
1.977 
4.658 
3.256 
3.256 
-
_ 
cal. deg"1 
ROS-poly(I) 
5.226 
4.436 
4.535 
3.948 
3.472 
3.525 
2.308 
1.865 
1.368 
1.379 
0.937 
-0.448 
. 
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Fig. 5. Profile of change in Gibb's free energy of denaturation for native poly(I) 
( - A - ) and ROS-poly(I) ( -O- ). 
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308.15°K (35°C) which decreased linearly to 0.937 K cal. deg-1 at 358.15° 
K (85°C) (Fig.5). Further elevation in thermal energy revealed a sharp transition 
in the AGD values from the positive scale towards the negative scale (Table 2). 
The AGD value was computed to be -0.448 K cal. deg"1 above 358.15°K i.e. 
at 363.15° K (90°C). 
Strand Breaks 
(a) Sephadex G-200 Gel Filtration 
To detect the formation of strand breaks in poly(I) following ROS-
modification, both native and ROS-poly(I) were passed through Sephadex G-200 
column. The elution pattern obtained (Fig. 6) shows a sharp and symmetrical peak 
in case of native poly(I), while ROS-poly(I) showed an additional minor peak. 
The additional peak obtained may be attributed to the generation of strand 
breaks. To calculate the modification occurred on poly(I) by ROS, the peak areas 
of the modified and unmodified polymer were calculated. ROS-poly(I) was found 
to be modified to the extent of 57.8%. 
(b) Agarose Gel Electrophoresis 
ROS-modified and native poly(I) were resolved by agarose gel 
electrophoresis on 1% agarose gel. ROS-poly(I) showed enhanced mobility as 
compared to native poly(I), thereby, indicating the generation of single strand 
breaks (Fig. 7). The ROS-poly(I) due to single strand breaks formation may also 
contain low molecular weight species, hence, causing enhanced mobility. Low 
intensity of band in case of ROS-poly(I) is attributed to single strand breaks. 
(c) Gel Diffusion of Native and ROS-Poly(I) 
To ascertain the enhanced mobility of ROS-poly(I) in comparison to native 
poly(I) on agarose gel, gel diffusion pattern of both native and modified poly(I) 
was observed spectrophotometrically. Lanes of native and ROS-poly(I) run on 
1% agarose were cut separately. Each lane was further sliced into 0.5 cm pieces. 
The individual slices were extracted by centrifugation and read at 248 nm. 
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Fig. 6. Elution profile of native poly(I) ( -O- ) and ROS-poly(I) ( - A _ ) on 
Sephadex G-200 column. Fractions of 3 ml were collected and monitored 
at 248 nm. 
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Fig. 7. Agarose gel electrophoresis of native poly(I) (lane 1) and ROS-poly(I) 
(lane 2). 
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Elution pattern, so obtained (Fig. 8) showed a marked shift in the peak in case 
of ROS-poly(I). The data confirms the high mobility of ROS-poly(I) due to strand 
breaks formation and generation of low molecular weight species. 
(d) Densitometric Scanning 
Native and ROS-poly(I) were resolved on 7.5% polyacrylamide gel and 
were subsequently subjected to densitometric scanning on gel-scanner GSC-3A 
equipped with Shimadzu UV-240 spectrophotometer, at a fixed wavelength of 
248 nm. The pattern obtained is depicted in figure 9. Poly(I) was found to be 
resolved as a single sharp peak, whereas, two broad peaks were observed in case 
of ROS-poly(I). These correspond to the native polymer and ROS-modified 
portion. The data indicated that considerable amount of poly(I) has been modified 
by ROS, which inturn may lead to strand breaks and thus low molecular weight 
species. 
Quantitation of the Modified Base 
Native and ROS-modified poly(I) were subjected to acid hydrolysis, in 
order to separate the modified and unmodified hypoxanthine base from the sugar 
phosphate backbone. UV absorption spectra of acid hydrolysed native and ROS-
poly(I) (Fig. 10) showed a shift of approximately 2 nm, i.e. from 248 to 250 nm 
(Xmax for hypoxanthine) and thus, indicates the release of hypoxanthine base. 
ROS-modification on the other hand showed broadening of the absorption 
maxima at around 250 nm. The results, therefore, indicate that perturbations or 
alterations have occurred in hypoxanthine base upon ROS-modification. 
The alterations incurred on poly(I) as a result of ROS- modification was also 
analysed by UV difference spectroscopy. Native poly(I), subjected to acid 
hydrolysis with respect to native poly(I) exhibited negative inversion with 
constant absorption. 
The UV difference spectral scanning of acid hydrolysed ROS-poly(I) was 
carried out by placing ROS-poly(I) as reference spectral control. As illustrated 
in figure 11, the spectral curve indicated an appreciable positive absorption in 
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Fig. 8. Gel diffusion pattern of native poly(I) ( - O - ) and ROS-poly(I) 
(-j£s-). Fractions of 0.2 ml were collected and monitored at 248 nm. 
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Fig. 9. Densitometric scanning of native poly(I) ( ) and ROS-poly(I) 
( ) on 7.5% native polyacrylamide gel. 
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10. UV absorption spectra of native poly(I) ( ), ROS-poly(I) ( ), 
acid hydrolyzed native poly(I) ( ) and acid hydrolyzed ROS-poly(I) 
( )• 
59 
200 300 
WAVELENGTH ( n m ) 
400 
Fig. 11. UV difference spectra of acid hydrolyzed native poly(I) versus native 
poly(I) ( ), acid hydrolyzed ROS-poly(I) versus ROS-poly(I) 
( ), acid hydrolyzed ROS-poly(I) versus acid hydrolysed native-
poly(I)( ). 
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between 400-285 nm followed by a sharp inversion of absorption i.e. negative 
absorption. Interestingly, this negative inverted absorption increased appreciably 
only till 277 nm. Whereas beyond 277 nm the test sample exhibited a constant 
absorption till 200 nm. Thus, no negative peak was observed. 
The UV-difference spectroscopical analysis of acid hydrolysed ROS-
poly(I) was taken against acid hydrolysed native poly(I) as reference. As 
evident from the spectral curves, negative absorption from 280-256 nm was 
observed. The negative invertedA was recorded at around 250 nm. However, 
° max * 
beyond 250 nm, a postive scale type peak/absorption within the negative scale 
of spectrum was observed in between 250-200 nm. The hydrolysate of native 
and ROS-poly(I) were then neutralized and applied to a DEAE Sephadex A-25 
column and eluted with a linear gradient of 1 to 20 mM Tris-HCl, pH 7.6. Figure 
12 shows the elution profile of hypoxanthine base. Figure 13 shows the elution 
profile of acid hydrolysed native and ROS-poly(I). Native poly(I) eluted in a 
single sharp peak similar to that obtained for hypoxanthine, while ROS-poly(I) 
was eluted in two distinct peaks. The minor peak corresponds to the unmodified 
hypoxanthine base, while the major peak corresponds to the modified base. The 
percent modification of base was determined by measuring the peak areas of both 
modified and unmodified poly(I) and was found to be 71.8. 
Antigenicity of Native and ROS-Poly(I) 
Antibodies against native and ROS-poly(I) were raised in rabbits. In order 
to evaluate the repertoire of specificties of the induced antibodies, direct binding 
and inhibition ELISA was performed. The binding of the induced antibodies, was 
further assessed by band shift assay. 
(a) Antibodies Against Native Poly(I) 
The antibodies raised against native poly(I) were found to be precipitating 
as detected by immunodiffusion and counterimmunoelectrophoresis (Figs. 14a 
and b). The antibody titre as ascertained by direct binding ELISA was found to 
be greater than 1:6400. Preimmune serum showed negligible binding (Fig. 15). 
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Fig. 12. Elution profile of standard hypoxanthine base ( -0- ) on DEAE Sephadex 
A-25 column. 
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Fig. 13. Fractionation of acid hydrolyzed native poly(I) (—O-) and ROS-poly(I) 
(-A- )on DEAE Sephadex A-25 column. 
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Fig. 14. (a)Immunodiffusion pattern of anti-native poly(I) antibodies with native 
poly(I). (b) Precipitation of anti-native poly(I) antibodies with native 
poly(I) studied by counterimmunoelectrophoresis. 
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Fig. 15. Direct binding ELISA of anti-native poly(I) antibodies. Immune serum 1 
( - ± - ) , immune serum 2 (-&-), preimmune serum ( -0- ) . Microtitre 
plates were coated with native poly(I) (5 ug/ml). 
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The specificity of induced antibodies was determined by competition assay (Fig. 
16). Induced antibodies were found to be highly specific for its immunogen. A 
maximum of 63.8% inhibition of antibody binding was observed. Fifty percent 
inhibition was observed at an inhibitor concentration of 3.6 ug/ml. 
(b) Antibodies Against ROS-Poly(I) 
Anti-ROS-poly(I) antibodies were also found to be precipitating antibodies 
(Figs. 17a and b.). The anti-serum showed a titre of 1:6400 by direct binding 
ELISA on plates coated with ROS-poly(I) (Fig. 18). Preimmune serum showed 
a low magnitude of binding. The specificity of these antibodies was checked by 
competition ELISA using immunizing antigen as inhibitor. The maximum inhibition 
in the antibody binding was 67%. Fifty percent inhibition was obtained at an 
inhibitor concentration of 4.5 ug/ml (Fig. 19). 
(c) Purification and Characterization of Immune IgG 
Immunoglobulin G against native and ROS-poly(I) were isolated from the 
respective sera by affinity chromatography on Protein-A Sepharose CL-4B 
column (Fig. 20). The purity of the IgG was ascertained by SDS-PAGE under 
non-reducing conditions (Fig. 20 inset). The purified IgG migrated as a single 
band. 
A high magnitude of binding of the purified anti-native poly(I) and ROS-
poly(I) with respective immunogen was exhibited by direct binding ELISA (Fig. 
21). No appreciable binding was observed in case of preimmune IgG. The 
specificity of the purified IgG was studied by competition assay. A maximum of 
71% inhibition of anti-native poly(I) IgG and 79% of anti-ROS-poly(I) IgG 
binding with respective immunogen as an inhibitor was observed (Fig. 22). Fifty 
percent inhibition was achieved at an inhibitor concentration of 8 ug/ml in case 
of native poly(I), while 1.8 ug/ml was required in case of ROS-poly(I). 
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Fig. 16. Inhibition of the binding of anti-native poly(I) antibodies to native poly(I). 
Immune serum 1 ( -0-) and immune serum 2 (-A-). Microtitre plates 
were coated with native poly(I) (5 u.g/ml). 
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Fig. 17. (a) ImmunodifAision pattern ofanti-R OS-poly(I) antibodies with R02-
poly(I). (b) Precipitation of anti-ROS-poly(I) antibodies with ROS-
poly(I). 
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Fig. 18. Direct binding ELISA of anti-ROS-poly(I) antibodies to ROS-poly(I). 
Immune serum 1 ( - ± - ), immune serum 2(-&- ), preimmune serum 
(-0-) . The microtitre plates were coated with ROS-poly(I) (5 ug/ml). 
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Fig. 19. Inhibition of anti-ROS-poly(I) antibodies binding with ROS-poly(I). 
Immune serum 1 ( -O- ), immune serum 2 ( -A- ) The microtitre 
plates were coated with ROS-poly(I) (5ug/ml) 
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Fig. 20. Elution profile of IgG from Protein A-Sepharose 4B affinity column. 
Inset: SDS-PAGE of purified IgG on 7.5% acrylamide gel. 
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Fig. 21. Direct binding ELISA of affinity purified anti-native poly(I) IgG with native 
poly(I) (-*-) , anti-ROS-poly(I) IgG with ROS-poly(I) (-&-)and pre-
immune IgG (-O-). 
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Fig. 22. Inhibition ELISA of anti-native poly(I)IgG binding to native poly(I) 
( ~ 0 - ) and anti-ROS-poly(I) IgGbinding to ROS-poly(I) ( -&-). 
Inhibitors were native poly(I) and ROS-poly(I) respectively. 
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Immuno-crossreactivity of Anti-Native Poly(I) Antibodies 
The antigenic specificity of the induced anti-native poly(I) antibodies was 
characterized by competition inhibition assay using nucleic acids, synthetic 
polynucleotides and bases as inhibitors. Competitive experiments with ROS-
poly(I) showed an inhibition of 55% in the antibody binding. Fifty percent 
inhibition was achieved at 15 ug/ml of ROS-poly(I) (Fig. 23). Total RNA from 
buffalo thymus showed an inhibition of 54%, while its modified conformer was 
inhibitory to an extent of 45% (Fig. 23). Native DNA from calf thymus showed 
a maximum of 51% inhibition, while, ROS-DNA showed an inhibition of 44% 
(Fig. 24). Nitrogenous base, guanine showed 54% inhibition in antibody binding 
activity, while ROS-guanine showed only 47% of maximum inhibition (Fig. 24). 
Among homopolymers, poly(G) showed an inhibition of 56%, poly(C) was found 
to be non-inhibitory, while poly(dA) showed negligible inhibition (Fig. 25). 
Poly(rG).poly(dC), a polymer known to attain A/-analogous conformation, 
resulted in 45% elimination in antibody binding (Fig. 26). 
The binding specificity of anti-native poly(I) antibodies with synthetic 
polydeoxyribonucleotides was also studied. Poly(dG-dC).poly(dG-dC) and 
poly(dI-dC).poly(dI-dC), showed an inhibition of 54% and 43% respectively 
(Fig. 26), while poly(dA-dU).poly(dA-dU), poly(dA-dT).poly(dA-dT) and 
poly(dA-dG)(dC-dT) showed negligible inhibitions (Fig. 27). Table 3 summarizes 
the inhibition data of anti-native poly(I) antibodies with different inhibitors. 
Immuno-crossreactivity of Anti-ROS-Poly(I) Antibodies 
Antigenic specificity of anti-ROS-poly(I) antibodies was also characterized 
by competition inhibition assay. When native poly(I) was used as an inhibitor, a 
maximum of 60% inhibition in the antibody binding was observed (Fig. 28). The 
concentration of native poly(I) required to inhibit 50% antibody activity was 4.5 
p.g/ml. Buffalo thymus native RNA showed a maximum inhibition of only 38%, 
while its ROS modified form showed a maximum inhibition to an extent of 58% 
(Fig. 28). A maximum inhibition of only 45% was achieved when native calf 
thymus DNA was used as an inhibitor, and a maximum of 55% was achieved with 
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Fig. 23. Inhibition of anti-native poly(I) antibody binding to poly(I). Microtitre 
plates were coated with native poly(I) (5 ng/ml). The competitors were 
ROS-poly(I) ( -O- ),ROS-RNA ( - a - ) and native RNA ( -*- ). 
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Fig. 24. Inhibition ELISA of anti-native poly(I) IgG binding to native poly(I). 
Microtitre plates were coated with native poly(I) (5 ng/ml). The 
competitors were native DNA ( - O - ), ROS-DNA ( - A - ), native 
guanine ( -A- ) and ROS-guanine ( - • - ). 
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Fig. 25. Inhibition ELISA of anti-native poly(I) antibody activity with poly(dA) 
( -0 - ) , poly(G) (-A-) and poly(C) ( -A- ) . The microtitre plates were 
coated with native poly(I) (5 ^ m l ) . 
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Fig. 26. Inhibition of anti-native poly(I) IgG binding to native poly(I) by poly(dI-
dC).poly(dl-dC) ( - o - ), poly(dG-dC).poly(dG-dC) ( _&- ) and 
poly(rG).poly(dC) ( - ± - )• The micfotitre plates werexpated with 
native poly(I) (5 ng/ml). 
78 
• i i i i i i 11 j i i i i 1 1 1 i i i i i i i _i i i i i i i 
0.01 0.1 10 100 
INHIBITOR CONCENTRATION ( jug/ml) 
Fig. 27. Inhibition of anti-native poly(I) IgG binding to native poly(I) by poly(dA-
dU).poly(dA-dU) (-O-), poly(dA-dT).(dA-dT) (-A-) and poly(dA-
dG).poly(dC-dT) (—±-). The microtitre plates were coated with native 
poly(I) (5 jig/ml). 
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TABLE 3 
Antigenic Specificity of Anti-Native Poly(I) Antibodies 
Inhibitor 
Poly(I) 
ROS-poly(I) 
RNA 
ROS-RNA 
DNA 
ROS-DNA 
Guanine 
ROS-guanine 
Poly(G) 
Poly(C) 
Poly(dA) 
Poly(rG).poly(dC) 
Poly(dG-dC).poly(dG-dC) 
Poly(dI-dC).poly(dI-dC) 
Poly(dA-dU).poly(dA-dU) 
Poly(dA-dT).poly(dA-dT) 
Poly(dA-dG).poly(dC-dT) 
Maximum % inhibition 
at 20 ug/ml 
71 
55 
54 
45 
51 
44 
54 
47 
56 
18 
23 
45 
54 
43 
05 
32 
36 
Concentration for 
50% inhibition 
(ug/ml) 
8.0 
15.0 
14.0 
-
9.0 
-
15.2 
-
16.0 
-
-
-
16.0 
-
-
-
-
Plates were coated with native poly(I) (5 ug/ml) 
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Fig. 28. Inhibition of anti-ROS-poly(I) IgG binding to ROS-poIy(I). Inhibitors 
were native poly(I) (-O-), ROS-RNA (-*- ) and native RNA ( -^ - ) . 
The microtitre plates were coated with ROS-poly(I) (5^g/ml). 
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ROS-DNA (Fig. 29). Guanine showed a moderate inhibition of 41%, while ROS-
guanine was found to inhibit antibody activity to a maximum of 60% (Fig. 29). 
The specificity of the anti-ROS-poly(I) antibodies was also assayed using 
homopolymers and synthetic double stranded polydeoxyribonucleotides. Poly(G), 
poly(C) and poly(dA) showed negligible inhibitions, while ROS-poly(G) exhibited 
a moderate inhibition of 41% (Fig. 30). Poly(dI-dC).poly(dI-dC), poly(dG-
dC).poly(dG-dC) and poly(rG).poly(dC) showed a maximum of 34%, 36% and 
27% respectively (Fig. 31), while poly(dA-dG).poly(dC-dT), poly(dA-
dU).poly(dA-dU) and poly(dA-dT).poly(dA-dT) were non-inhibitory (Fig. 32). 
Table 4 shows a summary of the binding characteristics of anti-ROS-poly(I) 
antibodies. 
Band Shift Assay 
To further ascertain the binding of native and ROS-poly(I) with respective 
immune IgG, band shift assay was performed. Varying amounts of immune IgG 
was incubated with constant amounts of respective immunogen for 2 hr at room 
temperature and overnight at 4°C. The immune complexes were then 
electrophoresed on 1% agarose for 2 hr at 30 mA. The formation of immune 
complex between anti-native poly(I) IgG and native poly(I) is depicted in figure 
33. With increasing IgG concentration the amount of immune complex formed 
also increased, whereas, the amount of unbound poly(I) decreases proportionally. 
The recognition of ROS-poly(I) by anti-ROS-poly(I) IgG was reiterated by the 
shift in the electrophoretic mobility as a result of immune complex formation (Fig. 
34). 
Detection and Quantitation of Anti-DNA Antibodies in SLE Sera 
Various SLE serum samples were tested for the presence of anti-DNA 
antibodies by direct binding ELISA. Out of the 30 serum samples tested, those 
showing high titer ranging from 1:1600 to 1:6400, of anti-DNA antibody binding 
are depicted in figures 35 and 36. The same samples were subsequently used for 
further studies. Normal human sera showed negligible binding. 
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Fig. 29. Inhibition of anti-ROS-poly(I) IgG binding to ROS-poly(I) by native 
guanine ( - O - ), ROS-guanine ( -A- )} native DNA ( -A—) and 
ROS-DNA( - • - ).The microtitre plates were coated with ROS-poly(I) 
(5ug/ml). 
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Fig. 30. Inhibition of anti-ROS-poly(I) IgG binding to ROS-poly(I). Inhibitors 
were native poly(G) ( -O—), native poly(C) ( - A - ), ROS-poly(G) 
( A )and poly(dA) (-#—). The microtitre plates were coated with 
ROS-poly(I) (5ug/ml). 
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Fig. 31. Inhibition of anti-ROS-poly(I) IgG binding to ROS-poly(I) by poly(dI-
dC).poly(dl-dC) ( - O - ), poly(dG-dC).poly(dG-dC) ( -&- ) and 
poly(rG).poly(dC) ( —±- ). The microtitre plates were coated with 
ROS-poly(I) (5ng/ml). 
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Fig. 32. Inhibition of anti-ROS-poly(I) IgG binding to ROS-poly(I). Inhibitors 
were poly(dA-dU).poly(dA-dU) ( - o — ), poly(dA-dT).(dA-dT) 
(—&-) and poly(dA-dG).poly(dC-dT) (—±-). The microtitre plates 
were coated with ROS-poly(I) (5ug/ml). 
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TABLE 4 
Antigenic Specificity of Anti-ROS Poly(I) Antibodies 
Inhibitor Maximum % inhibition Concentration for 
at 20 ug/ml 50% inhibition 
0*g/ml) 
Poly(I) 
ROS-poly(I) 
RNA 
ROS-RNA 
DNA 
ROS-DNA 
Guanine 
ROS-guanine 
Poly(G) 
ROS-poly(G) 
Poly(C) 
Poly(dA) 
Poly(rG).poly(dC) 
Poly(dG-dC).poly(dG-dC) 
Poly(dI-dC).poly(dI-dC) 
Poly(dA-dU).poly(dA-dU) 
Poly(dA-dT).poly(dA-dT) 
Poly(dA-dG).(dC-dT) 
60 
79 
38 
58 
45 
55 
41 
60 
16 
41 
14 
21 
27 
36 
34 
07 
14 
17 
Plates were coated with ROS-poly(I) (5 ug/ml) 
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Fig. 33. Band shift assay of anti-native poly(I) IgG binding to native poly(I). Native 
Poly(I) (5 ug) were incubated with buffer (lane 1) and with 25, 50, 75 
and 150 ug of IgG in lanes 2 to 5 respectively for 2 hr at 37°C and 
overnight at 4°C. Electrophoresis was performed on 1% agarose for 2 hr 
at 30 mA. 
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Fig. 34. Band shift assay of anti-ROS-poly(I) IgG binding to ROS-poly(I). ROS-Poly(I) 
(5 ug) were incubated with buffer (lane 1) and 25,50,75 and 150 ug of IgG in 
lanes 2 to 5 respectively for 2 hr at 37°C and overnight at 4°C. Electrophoresis 
was performed on 1% agarose for 2 hr at 30 mA. 
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Fig. 35. Evaluation of anti-DNA autoantibodies in SLE patients. The microtitre 
plates were coated with native DNA. SLE serum 1 (-A-), SLE serum 
2 ( - A - ), SLE serum 3 (—O—), SLE serum 4 ( - # - ), SLE serum 
5 ( - " ^ ) , SLE serum 6 (—h-). SLE serum 7 ( - • - ) and NHS (-0-). 
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Fig. 36. Evaluation of anti-DNA autoantibodies in SLE patients. SLE serum 8 
( - A - ), SLE serum 9 ( - A - ), SLE serum 10 ( -O- ) , SLE serum 
11 ( - # _ ) , SLE serum 12 ( - ^ - ) , SLE serum 13 ( - + - ) , SLE 
serum 14 (—(—) and NHS (—0—). The microtitre plates were 
coated with native DNA (2.5 ng/ml). 
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The specificities of these selected SLE sera against native DNA was 
ascertained by competition inhibition ELISA. Maximum inhibition ranging from 
45% to 66% in fourteen SLE sera (Figs. 37-39) was observed. Table 5 shows 
the inhibition data of anti-DNA autoantibodies binding to DNA in different serum 
samples. 
Immuno-crossreactivity of Anti-DNA Autoantibodies with 
Native and ROS-poly(I) 
To obtain the binding pattern of anti-DNA autoantibodies, from the sera 
of SLE patients, by native and ROS-poly(I), direct binding ELISA was 
performed. Almost all the SLE sera showed appreciable binding to native and 
ROS-poly(I). Preferentially high binding was observed in case of ROS-poly(I). 
Figure 40 shows the enhanced binding of SLE anti-DNA autoantibodies with 
ROS-poly(I) as compared to native poly(I)at 1:100 serum dilution. With normal 
human sera no appreciable binding was observed. 
Competition ELISA was also performed to further evaluate the specificity 
of each SLE serum for native and ROS-poly(I) (Figs. 41-47). In this case, 
antibody was first incubated with native or ROS-poly(I) and then assayed for 
residual binding with native DNA coated on microtiter plates. Maximum 
inhibitions ranging from 42-68% were observed. Relatively high percentage of 
inhibition was observed in case of ROS-poly(I) as an inhibitor. Table 6 
summarizes the inhibition results of anti-DNA autoantibodies binding to native 
DNA by native and ROS-poly(I). 
Purification of SLE IgG 
Protein-A binds IgG from most mammalian species through interactions with 
the Fc part of IgG molecules (Langone, 1978). SLE IgG was purified by affinity 
chromatography on Protein-A Sepharose CL-4B column. The purified IgG from 
normal and SLE sera were found to elute in a single symmetrical peak. The 
homogeniety of the IgG was confirmed by the presence of a single band on 
SDS-PAGE under non-denaturing conditions. 
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Fig. 37. Evaluation of anti-DNA autoantibody binding specificity to native DNA 
by inhibition ELIS A. SLE serum 1 (-O-), SLE serum 2 ( -A- ) , SLE 
serum 3 ( —Jk- ) , SLE serum 4( # ), SLE serum 5 ( —*7— )• The 
microtitre plates were coated with native DNA (2.5 ug/ml). 
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Fig. 39. Inhibition ELISA of SLE anti-DNA autoantibody binding with native DNA. 
SLE serum l l ( - O - ) , SLE serum 12 (—&-), SLE serum 13 (-A-) , 
SLE serum 14 (—•—). The microtitre plates were coated with native 
DNA(2.5 fig/ml). 
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TABLE 5 
Inhibition of the Binding of Autoantibodies from SLE Sera by 
Native DNA 
SLE serum Maximum % inhibition Concentration for 
at 20 ug/ml 50% inhibition 
(Ug/ml) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
44 
51 
47 
56 
58 
50 
57 
63 
61 
66 
64 
58 
50 
59 
-
16 
-
19 
20 
20 
17 
16 
17 
09 
15 
15 
20 
15 
Plates were coated with native DNA (2.5 ug/ml) 
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Fig. 40. Direct binding ELISA of human SLE anti-DNA autoantibodies to native 
poly(I) ( M ) and ROS poly(I) ( ^ m )• 
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Fig. 41. Inhibition ELISA of SLE anti-DNA autoantibodies from two SLE patients 
(1 and 2). The inhibitors used were native poly(I) (A,0) and ROS-
poly(I) (A,#-). The microtitre plate was coated with native DNA (2.5 
ug/ml). 
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Fig. 42. Inhibition of SLE anti-DNA autoantibodies (3 and 4) by native poly(I) 
(A,0 ) and ROS poly(I) (A, • ) . The microtitre plate was coated with 
native DNA (2.5 ug/ml). 
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Fig. 43. Inhibition of SLE anti-DNA autoantibodies derived from SLE sera 
( 5 and 6). The competitors were native poly(I) (&yO) and ROS 
poly(I) (A,-*-)- The microtitre plate was coated with native DNA (2.5 
ug/ml). 
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Fig. 44. Inhibition ELISA of SLE anti-DNA autoantibodies from SLE sera (7 
and 8). The competitors were native poly(I) ( A , 0 ) and ROS poly(I) 
(Af#-). The microtitre plate was coated with native DNA (2.5 ug/ml). 
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Fig. 45. Competition immunoassay of SLE anti-DNA autoantibodies from SLE 
sera (9 and 10). The competitors were native poly(I) (A}<» and ROS 
poly(I) (*-,•)• The microtitre plate was coated with native DNA (2.5 
Hg/ml). 
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Fig. 46. Inhibition of SLE anti-DNA autoantibodies derived from SLE sera 
(11 and 12). The inhibitors were native poly(I) (A,0) a n d ROS poly(I) 
(*•,-#-). The microtitre plate was coated with native DNA (2.5 ug/ml). 
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Fig. 47. Inhibition ELISA of SLE anti-DNA autoantibodies from SLE sera 
(13 and 14). The competitors were native poly(I) (-&,-(> ) and ROS 
poly(I) (Ay#-). The microtitre plate was coated with native DNA (2.5 
ug/ml). 
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TABLE 6 
Inhibition of Anti-DNA Autoantibodies Binding to Native DNA 
by Native and ROS-PoIy(I) 
SLE serum Maximum percent inhibition at 20 ng/ml 
Native poly(I) ROS-poly(I) 
42 
46 
37 
47 
44 
47 
54 
44 
47 
33 
54 
41 
39 
43 
64 
68 
54 
57 
52 
68 
55 
68 
63 
50 
53 
64 
58 
68 
Plates were coated with native DNA (2.5 ng/ml) 
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The binding activity of purified SLE IgG with native and ROS-poly(I) was 
studied by direct binding ELISA. High magnitude of binding was observed with 
ROS-poly(I) as compared to native poly(I) (Fig. 48a), while normal human IgG 
showed negligible binding. The binding specificity was further ascertained by 
inhibition ELISA. A maximum inhibition of 58% was observed in case of native 
poly(I), while 69% was observed when ROS-poly(I) was used as an inhibitor (Fig 
48b). 
Quantitative Precipitin Titration 
The antigen-antibody interaction was also characterized by quantitative 
precipitin titration. Varying amounts of modified, unmodified poly(I) and native 
DNA (0-50ug) were mixed with 100 ug of SLE IgG and incubated for 2 hr at 
37°C and 72 hr at 4°C. The results obtained were typical of precipitin titration 
curves (Figs. 49-51.). ROS-poly(I) showed maximum antibody binding at an 
antigen concentration of 20 ug, while native poly(I) and native DNA bound 
maximally at 30 ug. Protein analysis of immune complexes showed that 78 ug of 
SLE IgG bound to ROS-poly(I), 66 ug with native poly(I) and 72 ug with native 
DNA. Further analysis of precipitin data revealed that 3 ug, 1.6 ug and 2 ug of 
SLE IgG/ug of ROS-poly(I) , native poly(I) and native DNA respectively were 
required for immune complex formation. The affinity constant of anti-native DNA 
antibodies was evaluated by Langmuir analysis (Fig. 52) and apparent association 
constant was computed to be 3.0 x 107 M, 3.8 x 106 and 9.0 x 105 M for ROS-
poly(I), native DNA and native poly(I) respectively. 
Band Shift Assay 
Further analysis of binding of anti-DNA antibodies with native poly(I) and 
ROS-poly(I) was performed by gel retardation assay. With increasing amounts 
(0-150 ng/ml) of SLE IgG, a constant amount of antigen was added and incubated 
for 2 hr at 37°C and overnight at 4°C. The immune complexes were then 
electrophoresed on 1% agarose for 2 hr at 30 mA. Figures 53 and 54 show the 
binding of anti-DNA autoantibodies with native and ROS-poly(I) respectively. As 
the concentration of IgG increases, there is corresponding increase in the 
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Fig. 48. (a) Direct binding ELISA of Protein-A-Sepharose purified SLE IgG with 
native poly(I) (—Jt-) and ROS-poly(I) (—A—). The microtitre plate 
was coated with native DNA (2.5 ug/ml). (b) Inhibition of the binding of 
affinity purified SLE IgG to native DNA by native poly(I) 
(—O—) and ROS-poly(I) (—A—). The microtitre plate was coated with 
native DNA (2.5 ug/ml). 
107 
* 
a 
>-
< 
IM
T 
O 
s & 
>-
o 
o 
9 
Z 
100 
8 0 
60 
4 0 
2 0 
0 
1 0 0 
10 20 30 40 
ANTIGEN ADDED ( jig) 
10 20 30 4 0 
ANTIGEN ADDED ( jig) 
Q 
UJ 
< 
H 
tt. 
O 
UJ 
cc 
a 
z: 
u. 
a P 
z 
<: 
/ 
Fig. 49. Quantitative precipitin titration curves of SLE IgG with ROS-poly(I) 
( - ± - ) and normal human IgG ( —&- ). 
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Fig. 50. Determination of antigen and antibody bound by SLE IgG (-A-) and 
normal human IgG (—A-). The antigen used was native poly(I). The 
assay was performed by quantitative precipitin titration. 
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Fig. 51. Evaluation of SLE anti-DNA autoantibodies binding by quantitative 
precipitin titration. The antigen used was native DNA. 
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Fig. 52. Determination of antibody affinity by Langmuir plot. Antigens used were 
ROS-poly(I) ( -A-) , nativepoly(I) (-€>-) and native DNA ( - # - ) . 
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Fig. 53. Band shift assay of SLE IgG binding to native poly(I). Native poly(I) (5 
Hg) were incubated with buffer (lane 1) and 20, 40, 75 and 150 ng IgG 
through lanes 2 to 5 respectively for 2 hr at 37°C and overnight at 4°C. 
Electrophoresis was performed on 1% agarose for 2 hr at 30 mA. 
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Fig. 54. Band shift assay of SLE IgG binding to ROS-poly(I). ROS-poly(I) 
(5 ug) were incubated with buffer (lane 1) and 20, 40, 75 and 150 ug 
IgG through lanes 2 to 5 respectively for 2 hr at 37°C and overnight at 
4°C. Electrophoresis was performed on 1% agarose for 2 hr at 30 mA. 
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formation of high molecular weight immune complexes, thereby, causing a 
corresponding decrease in the intensity of the unbound antigens. Under identical 
conditions when normal human IgG was incubated, it did not show any immune 
complex formation. 
Detection of Immune Complex(es) Deposition in Kidney 
Direct binding ELISA results showed the induction of high titer antibodies 
against native and ROS-poly(I) in rats (Figs. 55a and b). Sera of rats immunized 
with adjuvant only did not show any significant binding with native and ROS-
poly(I). Preimmune sera showed negligible binding. Immunofluorescence of the 
kidney sections of rats immunized with native and ROS-poly(I) showed an apple 
green fluorescence, thus, depicting the deposition of immune complex (Fig. 56). 
Normal rat kidney section did not show any deposition of immune complex. 
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(a) Direct binding ELISA of immune (• ,O^,A), preimmune ( 0 ) and 
adjuvant immunized (*,v) rat serum antibodies to native poly(I). Microtitre 
plates were coated with native poly(I) (5 ug/ml). (b) Direct binding ELISA 
of immune (• ,o ,A,A), preimmune ( • ) and adjuvant immunized 
(•,v) rat serum antibodies to ROS-poIy(I). Microtitre plates were coated 
with ROS-poly(I) (5 ug/ml). 
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Fig. 56. (a) Immunofluorescence of kidney sections from rats immunized with 
native-poly(I). Immune complexes deposition in the glomerulus were seen 
under fluorescent microscope, using anti-rat-FITC conjugate, (b) 
Immunofluorescence of kidney sections from rats immunized with ROS-
poly(I). Immune complexes deposition in the glomerulus were seen under 
fluorescent microscope, using anti-rat-FITC conjugate. 
(MMMbCm 
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i e capacity of individuals to discriminate self from non-self is vital to 
the func ioning of the immune system, to defend against invading microorganisms. 
Discrimination between self and foreign structures operates through an active 
process that involves several different mechanisms including clonal deletion, 
clonal a lergy and suppression. The failure of these regulatory mechanisms leads 
to the persistence and activation of potentially self reactive cells and the 
development of autoimmune disorders which can result in pathological 
autoimnune states. Autoimmune diseases have been associated with a myriad of 
immunological abnormalities ranging from increased pro-inflammatory cytokines, 
increased expression of major histocompatibility complex molecules, skewing of 
T cell r ;ceptor repertoire, increased numbers of B cells and pathogenesis of the 
various autoimmune disorders. This failure is probably due to complex processes 
involved in immune recognition and regulation. Studies in experimental animals 
support the notion that autoimmune diseases may result from a wide spectrum of 
genetic and immunologic abnormalities, which differ from one individual to 
anothe and may express themselves early or later in life, depending on the 
presence or absence, respectively, of many super-imposed exogenous (virus, 
bacteria) or endogenous (hormones, abnormal genes) accelerating factors. As 
reseanh in autoimmunity progresses, several important issues need to be 
resolv:d. The most urgent of these, concerns the nature of the inciting antigen 
which has been masked by three areas of ambiguity. First, uncertainty in the 
identified autoantibodies and corresponding antigen's involvement in the 
pathogenesis of a given disease. Second, difficulties in the identification of the 
inciting antigen, due to the immense diversity of autoantibodies observed in some 
diseases. Third, there is uncertainty as to whether the initial trigger has any 
relatic n to the antigen recognized by the autoantibody (Mongey and Hess, 1993; 
Levinjson, 1994; Mountz et al., 1994; Radic and Weigert, 1994; Theofilopoulos, 
1995) 
High serum levels of anti-nuclear antibodies in patients suffering from 
vario is autoimmune disorders is of considerable importance. These naturally 
occuiring antibodies not only provide diagnostic and prognostic parameters to 
clinic ians, but also give molecular biologists a valuable tool for the better 
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understanding of cellular processes (Woodruff et al., 1986). Systemic lupus 
erythematosus (SLE) is an autoimmune disorder with elevated levels of 
autoantibodies causing tissue injury (Steinberg, 1991; Hahn, 1993). Amongst 
various autoantibodies, IgG reactive with double stranded DNA (dsDNA) are 
diagnos ic of the disease and contribute to renal pathology. In addition, anti-DNA 
autoant bodies have been shown to be enriched in glomerular eluates of SLE 
patients 
ENA alone has generally been found not to be immunogenic. Repeated 
attempts to specifically induce anti-DNA antibody with characteristics similar to 
that produced in autoimmune mice have met with limited success (Stollar, 1989). 
It is noj known whether some form of DNA, such as a product of viral infection 
or a fragment of chromatin or chemically modified DNA, serves as an immunogen. 
It may >e that some other structure stimulates the response and native DNA is 
actuall / a cross reacting antigen. 
It has been suggested by several groups that ROS may contribute to the 
development of both rheumatoid arthritis (RA) and SLE and both are considered 
to have ROS-related etiologies (Halliwell, 1982). In particular, ROS-modification 
of both IgG (Griffiths and Lunec, 1996) and DNA (Blount et al., 1989) can 
render these macromolecules more susceptible to forming interactions with 
circukting autoantibodies in RA and SLE respectively, thus promoting immune 
compl 5X formation, which may be important in their pathogenesis. ROS 
modif cation of DNA does appear to expose epitopes on the DNA that are 
recogr ised by circulating anti-DNA antibodies in SLE sera (Blount et al., 1994; 
Ashok and Ali, 1998). It has been proposed that in chronic inflammatory diseases 
such i s RA and SLE, highly reactive oxygen species released from activated 
phago:ytic cells at the site of injury may penetrate cellular membranes and react 
with mclear DNA (Stollar, 1981; Lunec et al., 1987; Allan et al., 1988). 
Subsequent release of this altered DNA may enable it to act as an antigen against 
whicl anti-DNA autoantibodies could be raised. Lymphocytes isolated from 
patients suffering from RA and SLE have also been found to contain increased 
level; of 8-OH-dG in DNA (Bashir et al., 1993). The increased level was found 
to be (significantly high in SLE patients than in RA patients (Lunec et al., 1994). 
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T le binding diversity of lupus autoantibodies to a whole spectrum of 
modified nucleic acid conformers (AH et al., 1991; Alam and Ali, 1992; Alam 
et al., 1992;1993; Arif et al., 1994; Arjumand and Ali, 1994; Klinman et al., 
; Moinuddin 1994; oinuddin and Ali, 1994; Arjumand et al., 1995; Ahmad et al., 1997) 
seems to be enormous. The efforts to understand the origin and consequence of 
anti-Dh A autoantibodies are still in progress. For these reasons, it was thought 
desirable to investigate the antigenicity and binding characteristics of native and 
ROS-modified poly(I). 
Y uman exposure to reactive oxygen species has been implicated in the 
etiology of a number of human autoimmune diseases, due to the formation of 
modified DNA bases. The promutagenic 8-OH-dG in particular, is a 
roduct (Povey et al., 1993). Cellular DNA is damaged by oxygen free 
5 generated during cellular respiration, cell injury, phagocytosis and 
e to environmental oxidants (Floyd et al., 1986; Fridovich, 1986; Kasai 
1986; Klebanoff, 1988; Breimer, 1990). 
' 
various 
major \ 
radical 
exposu 
et al., 
In the present study, the hydroxyl radical generated by the irradiation of 
hydrogen peroxide by 254 nm light was found to cause extensive damage to 
poly(I", a ribohomopolymer. The absorption of poly(I) decreased at 248 nm 
(Xmax )with increasing duration of UV irradiation. The hypochromicity in ROS-
poly(I could be due to modification of the base. 
The UV difference spectral curves for ROS-poly(I) with respect to native 
poly(I revealed a negative inversion absorption between 300-280 nm, followed 
by a c<mstant absorption between 200-280 nm. The elimination or disappearance 
of the expected peak at the Xmax in between 200-280 nm is suggestive for the 
loss o "chromophoric groups in substantial amounts, resulting in ROS-induced 
damage of inosine or hypoxanthine moieties in poly(I). However, as evident from 
the sj ectral curves, a pronounced damaging effect on the structure of sugar 
moiety of poly(I) was not exhibited by ROS, as judged on the basis of a small 
positi ve scale like peak in the negative scale, devoid of any absorption inversion 
in the UV spectral range of 200-230 nm. X-ray diffraction studies had shown the 
existence of poly(I) in multi-stranded form (Zimmerman et al., 1975). Base 
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stacking as well as hydrogen bonding are involved in stabilizing the native 
structu e of poly(I). Poly(I) was also found to form a stable complex with 
poly(C . Change in absorbance ratio (A250/A260) from 1.13 in case of 
poly(I).poly(C) complex to 0.93 in ROS-poly(I).poly(C), suggests for the 
modifi( ation/perturbation in hypoxanthine base due to 'OH radical exposure. 
Appreciable evidence for the structural changes in native poly(I) as a 
consequence of ROS-induced perturbations was revealed by analysing the data 
and computation of thermodynamic parameters. Native poly(I) displayed a 
positive Gibb's free energy for denaturation (AGD) in the entire thermal spectrum 
i.e. be ween 30°C to 95°C, thereby, suggesting the absence of Watson-Crick 
type base pairing between the strands of the tetramer and instead is indicative 
for the ionic interaction between base of one strand with the backbone of other 
strand i.e. base to backbone interaction. Moreover, the positive AGD values 
observed is also suggestive of the fact that all the portions of the poly(I) tetramer 
were already in unstacked form and that all the four strands of poly(I) were held 
together by non-base to base interacting force(s). Thus, the results are 
suggea tive for the thermodynamically less stable nature of the poly(I) tetramer 
due to the absence of base to base type interaction(s). 
In contrast to native poly(I), the poly(I) subjected to ROS induced 
perturbations exhibited interesting results. As in case of native poly(I), a positive 
AGD was observed for the ROS-poly(I), but it persisted till 358.15°K and 
beyond it a sharp transition of the AGD values from the positive scale towards 
the negative scale was observed. The positive AGD values till 358.15°K is 
suggestive for the non-base to base type interactions in the modified polymer, 
althoi gh the degree of such an interaction was of lower magnitude than the native 
confermer. The presence of negative AGD values in between 358.15°K to 
363.15°K is suggestive for the introduction of some amount of ROS induced 
covalent base-base interactions or covalent interactions nearly similar in nature 
to it, apart from the base-backbone type interaction(s) in ROS-poly(I) tetramer. 
Moreover, it could be inferred from thermodynamic parameters that ROS-poly(I) 
tetramer was atleast, partially thermodynamically more stable than native poly(I) 
tetramer. Furthermore, the thermodynamic parameters are suggestive for the 
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introd I action of an appreciable degree of partial compactness in the poly(I) 
tetramer by reactive oxygen species, particularly at the covalently modified sites 
in cortrast to native poly(I) teramer. Moreover, the appreciable degree of 
hyperchromism displayed by UV spectral curves of ROS-poly(I) which was 
thermally agitated to 95°C , further reiterates the above argument. 
to sug 
Hydroxyl radical abstracts hydrogen atoms from deoxyribose, giving rise 
ar radical that can fragment in various ways. Reactions of deoxyribose-
derived radicals can lead to the release of purine and pyrimidine bases from the 
DNA (producing abasic sites) and to strand breaks (Halliwell and Aruoma, 
1991) Photochemical changes have also been found to occur in purine and 
pyrimidine bases on attack of'OH radical. Pyrimidines in DNA are attacked to 
give several products like thymine and cytosine glycols (Breen and Murphy, 
1995). Of the purines, OH can add on to guanine residues to give 8-hydroxy-
guani le (Lunec et al., 1994). 
To determine the participation of hydroxyl radical in mediating alterations 
in hyr, oxanthine residue, UV absorption and difference spectra of acid hydrolysed 
nativ^ and modified poly(I) were compared. 
Attack of OH upon DNA produces a multiplicity of different products (von 
Sonnjag, 1987; Steenken, 1989; Dizdaroglu, 1990). Hydroxyl radical damage to 
DNA leads to single strand breaks (Breen and Murphy, 1995) and modification 
of all four purine and pyrimidine bases. Photoionization of polynucleotides and 
DNA could lead to the formation of electron loss centres localized at the guanine 
moie y (Candeias et al., 1992). Strand breaks have been known to be induced 
in polynucleotides by sulphate radical anion (Wolfe/ al., 1993). 
The presence of single strand breaks in poly(I) following modification with 
hydrf>xyl radical was studied by Sephadex G-200 gel chromatography. Native 
poly I) was found to elute as a single sharp symmetrical peak, thereby, indicating 
the orderedness of the native conformer. On the other hand, ROS-poly(I) showed 
an additional minor peak. 
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Of the two peaks obtained in case of ROS-poly(I), one corresponds to 
the na ive structure while the other constitutes 57.8% of the total ROS-poly(I) 
applied to the column. This additional peak may be attributed to the generation 
of s tnnd breaks which in turn leads to the formation of low molecular weight 
species. 
The generation of single strand breaks was also resolved by agarose gel 
electrophoresis. On electrophoresis, ROS-poly(I) showed enhanced mobility and 
low intensity as compared to native poly(I). This was further ascertained by their 
elutio 1 profile after extraction from the agarose gel, which showed a shift in the 
peak fraction in case of ROS-poly(I), hence, confirms the enhanced mobility of 
ROS-]>oly(I). The observed difference in the mobility of native and modified 
poIy(]) may be a consequence of hydrogen peroxide exposure. The resulting 
electDphoretic pattern clearly indicates the formation of strand breaks, which 
result id in high mobility and modification of base which contributes to the low 
intensity of the band. It seems, therefore, that hydrogen peroxide in presence of 
UV li ;ht affects the secondary structure of poly(I). 
Densitometric scanning of native and ROS-poly(I) following 
electr phoresis on 7.5% native acrylamide gel was performed to further ascertain 
the formation of strand breaks by the attack of hydroxyl radical. Poly(I) was 
found to be resolved in a single peak, while its modified conformer showed two 
broad peaks. The results are again indicating that on exposure to UV in presence 
of H202, hydroxyl radical leads to strand breaks which resulted in the formation 
of lov molecular weight species. 
The UV absorbtion spectra of acid hydrolysed native poly(I) showed Xmax 
at 250 nm which is typical of hypoxanthine base and thus, indicates the release 
of hy joxanthine base on hydrolysis. In case of ROS-poly(I), broadening of the 
absorption maxima at 250 nm is indicative of the alteration in hypoxanthine base 
on R(|)S modification. 
Poly(I) subjected to acid hydrolysis exhibited complete damage of the 
sugat moiety as well as the hypoxanthine base(s), as revealed by UV difference 
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spectroscopy of acid hydrolysed poly(I) with respect to native poly(I). Attempts 
were also made to have further insight on the acid hydrolysed induced effect only 
on ROS-poly(I). The effect of ROS on poly(I) was eliminated from acid 
hydrolysed ROS-poly(I) by keeping ROS-poly(I) as a spectral reference. The 
results are indicative for the loss or damage of inosine(s) bases to an 
appreciable extent. In contrast to the above, the effects induced by ROS only 
on acid hydrolysed poly(I) was probed by using acid hydrolysed poly(I) as 
spectral reference, thus, eliminating the effect of acid hydrolysis on ROS-
poly(I). The observed spectral curves indicate the presence of two different 
types of moieties in the ROS-poly(I). One comprising of modified hypoxanthine 
corresponding to the negative inverted Xmt% at 250 nm, whereas, second 
comprises of a mixture of separated unmodified as well as modified sugar 
phosphate backbone, corresponding to the increase in absorbance at around 
220 nm. 
Well defined modification of upto 71.8% in hypoxanthine base as 
determined by ion exchange chromatography experiment further ascertain the 
modifying effects of hydroxyl radical. These results are consistent with the earlier 
studies which demonstrate the susceptibility of DNA bases like thymine and 
guanine to modification by hydroxyl radical (Demple and Linn, 1982; Hutchinson, 
1985; Yamamoto and Kawanishi, 1989; Rosen et al, 1996; Tritschur et al, 
1996). 
Native DNA per se is known to be a poor immunogen (Madaio et al, 
1984; Stollar, 1986), whereas, double stranded RNA, RNA-DNA hybrids, 
double helical polydeoxyribonucleotides, synthetic ribohomopolymers poly(I), 
poly(G) and poly(U) and calf thymus DNA modified with drugs, hormones, free 
radicals etc. have been reported to induce antibodies (Stollar, 1973; 1975; 
1986) Anderson et al, 1988; Desai et al., 1993; Moinuddin and Ali, 1994; 
Arjumand et al, 1995; Theofilopoulos, 1995). 
However, a number of synthetic analogues of DNA (e.g. Z-DNA, A-DNA, 
certain right handed helical double-stranded polydeoxyribonucleotides have been 
of considerable interest as immunogen (Stollar, 1986; Anderson et al, 1988). 
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Recent evidence suggests that DNA from various species differ in their 
immunological activity (Messina et al., 1993). 
A variety of bi-or-trihelical polynucleotide structures induce the formation 
of specific antibodies directed towards conformational epitopes and these 
recognize macromolecular structure (Lacour et al., 1973). 
Immunogenicity of a ribohomopolmer, polyinosinic acid [Poly(I)] and its 
hydroxyl radical modified counterpart [ROS-poly(I)] has been investigated in the 
present study. Poly(I) is known to assume a variety of conformations, from single 
to four stranded structures and it may contain its pentoses in a C-2-endopucker, 
a conformation characteristic of DNA. 
Direct binding and inhibition ELISA revealed high immunogenicity of both 
native and ROS modified poly(I). Visual detection of the immune complex 
formation between antigen and antibody by band shift assay clearly demonstrated 
the specificity of the purified immune IgG towards the respective immunogen. 
Anti-native poly(I) serum shows a maximum inhibition of 63% while 
purified anti-native poly(I) IgG showed a maximum inhibition of 71%. Fifty 
percent inhibition in the anti-native poly(I) IgG binding activity was achieved at 
8 ug/ml. Thus, indicating the higher specificity of the purified IgG as compared 
to serum. ROS modified conformer of native poly(I) showed a maximum inhibition 
of only 55%. This cross reactivity maybe due to the recognition of an antigenic 
determinant common to both native and ROS-poly(I). 
Competition immunoassay using native RNA and DNA showed maximum 
inhibitions of 58% and 53%, while their ROS counterparts showed maximum 
inhibitions of 45% and 44% respectively. The data, thus, suggests preferentially 
higher recognition of native conformer by anti-native poly(I) IgG over ROS-
modified poly(I). Also immune IgG recognizes the phosphodiester backbone in 
preference. The inhibition ELISA results with a nitrogenous base guanine and its 
ROS modified form as an inhibitor, further ascertain the preferential binding of 
native form over modified conformer. Moderate inhibition of poly(G) in contrast 
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to poly(C) and poly(dA) as inhibitors suggest the recognition of some of the 
epitopes shared by poly(G) and poly(I). Inhibition studies of the double stranded 
polynucleotides indicate the polyspecificity of the induced antibodies, which 
might be due to the recognition of the phosphodiester backbone. 
Systemic lupus is a multisystem, inflammatory disorder characterized by the 
production of autoantibodies of multiple specificity, specially antibodies reactive 
with nuclear antigens, including DNA (Andrews et al., 1978; Smith and 
Steinberg, 1983; Tan, 1985; Steinberg et al., 1990;1991; Steinberg, 1992; 
Harada et al., 1994). Although these anti-DNA autoantibodies serve as a marker 
of diagnostic significance in SLE (Mineter et al., 1979; Swaak et al., 1979; Tan, 
1982), attempts at immunization with native mammalian DNA without protein 
carrier or adjuvant have been largely unsuccesful. However, Z-DNA and bacterial 
DNA are found to be immunogenic (Gilkeson et al., 1989). Wilusz and Keene 
(1986) demonstrated the existence of autoantibodies specifically reactive with 
sequences and structures in RNA molecules. In addition, Hoet et al. (1992) have 
presented evidence that anti-Ul RNA autoantibodies correlate with the severity 
of disease in a manner similar to that of anti-DNA autoantibodies. 
Blount et al. (1991) postulated that DNA damaged by ROS may contribute 
for the development of autoimmune diseases such as SLE. The hypothesis that 
ROS modification of DNA is involved in the development of autoantibodies in 
SLE has been supported by the enhanced reactivity of SLE anti-DNA 
autoantibodies to ROS denatured DNA (Blount et al., 1989;1990; Cooke et al., 
1997). Further evidence of the antigenic potential that ROS modified DNA has 
for SLE sera is provided by the study conducted by Alam et al. (1993). 
Anti-ROS-poly(I) showed a strong recognition of the immunogen. With 
ROS-poly(I) as an inhibitor, purified immune IgG showed an inhibition of 77%, 
while its immune serum showed an inhibition of 68%. Only 4.5 ug/ml of ROS-
poly(I) was required to achieve 50% inhibition, thus, showing the higher 
specificity of the purified IgG. Further, the higher recognition of the purified IgG 
towards immunogen was reiterated by the retarded mobility of the immune 
complex in band shift assay. Wide cross reactivity and polyspecificity of the 
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antibodies was observed with preferential recognition for ROS-modified 
conformers. ROS-RNA and ROS-DNA showed an inhibition of 58% and 55%, 
while native RNA and DNA showed an inhibition of 48% and 44%. 
Studies have shown the high susceptibility of guanine base to modification 
on exposure to hydroxyl radical and 8-OH-G is the major product (Wei and 
Frenkel, 1991; Lunec et al., 1994). A maximum inhibition of 60% was observed 
by anti-ROS-poly(I) IgG, when ROS-guanine was used as inhibitor, while with 
native guanine it was only 41%. The data, thus, indicates the higher specificity 
of the immune IgG towards ROS modified epitopes of guanine. Modification of 
guanine by ROS might have generated potential epitopes against which the 
antibodies are raised. The detection of 8-OH-G in the immune complex derived 
DNA of SLE (Lunec et al., 1994) reinforces the evidence that ROS may be 
involved in the development of SLE. 
In the present study, the second aspect that is probed, is the possible 
association of the ROS-modified and the unmodified polyinosinic acid with SLE. 
The study was conducted in view of the progressive increase of autoantibodies 
against nucleic acid polymers in SLE. Studies have shown that base specificity 
is prominent in the recognition of the human myeloma proteins, and that the 
acessible epitopes in single stranded polynucleotides become masked upon base 
pairing in double-stranded helices (Zouali and Stollar, 1986). Myeloma proteins 
have also been found to show idiotypic determinants with human autoantibodies 
from lupus patients (Neparstek et al., 1985). Polymers containing the purines, 
guanine or hypoxanthine or the pyrimidine, thymine were most reactive with these 
proteins (Zouali and Stollar, 1986). 
A group of patients with the inflammatory conditions of SLE were used to 
study the possible role of ROS induced damage to a ribohomopolymer [poly(I)], 
in inflammation. High titre of anti-DNA autoantibodies were observed in sera of 
SLE patients, collected for the present study. Of these, 14 SLE sera were found 
to show an inhibition in the anti-DNA antibody binding, ranging from 45 to 66%. 
Thus, showing the specificity of these autoantibodies towards native DNA. When 
reactivity of native and ROS-poly(I) with SLE sera was probed, direct binding 
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ELISA results showed the preferential binding of ROS-poly(I) over native 
poly(I). Further, competition immunoassay, substantiated the above results, with 
native poly(I) showing an inhibition ranging from 33% to 54%, while ROS-poly(I) 
showing inhibitions in the range of 50% to 68%. Results with purified SLE IgG 
further reiterates the preferential binding of ROS-poly(I) over native poly(I), as 
observed by direct binding and inhibition ELISA. Band shift assay further 
substantiated the binding of native and ROS-modified poly(I) with anti-native 
DNA autoantibodies. 
To have a better insight into the recognition of anti-native DNA 
autoantibodies in SLE sera with native and ROS-poly(I), quantitative precipitin 
titration was also performed. From the Langmuir plot, affinity constant was 
calculated. In case of ROS-poly(I), the apparent association constant was 
computed to be 3 x 107 M, for native poly(I) it was 9 x 105M and for native 
DNA it was 3.8 x 106 M. Thus, showing greater recognition of ROS-poly(I) as 
compared to native DNA and native poly(I) by SLE anti-DNA autoantibodies. 
These studies further substantiated and reiterated the binding patterns observed 
by ELISA and band shift assay. 
Clinically, titers of the autoantibodies to double stranded DNA (dsDNA) 
are closely related to the activity of the renal inflammation. Other polynucleotide 
antibodies may combine with circulating antigen at any stage of the disease and 
contribute to the deposition of immune complexes in renal glomeruli (Koffler et 
al., 1974). It has been suggested that both the site of immune deposit formation 
and the resulting pathologic and clinical abnormalities may be dependent on 
properties unique to subsets of anti-DNA autoantibodies (Raz et al., 1989; 
Vlahakos et al., 1992a). In view of these observations, kidney sections from rats 
immunized with native and ROS-poly(I) and showing high titers of induced 
antibodies were screened for the deposition of immune complexes in the 
glomerulus. Immunoflourescence study showed the deposition of immune complex 
in the kidney as detected by an apple green flourescence. This observation is 
consistent with the studies conducted by Koffler et al. (1974), which showed 
the presence of anti-DNA autoantibodies in immune complexes deposits in the 
glomeruli of SLE patients. These findings could suggest that antibody-ligand 
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interactions participate in immune deposit formation in individuals with lupus and 
the predominant autoantibody-autoantigen interaction(s), in a given individual, 
influence both the morphologic and the clinical expression of nephritis. 
These results demonstrate the high susceptibility of the bases in DNA or 
RNA to ROS-modification in inflammatory diseases like SLE. Modified DNA 
bases and nucleosides have been detected in urine of humans (Halliwell and 
Aruoma, 1991). The strong binding potential of anti-DNA IgG towards ROS-
modified polynucleotides demonstrate the possible participation of a modified 
nucleotide in SLE pathogenesis. The spontaneous production of anti-DNA 
autoantibodies in SLE might arise as a consequence of antigenic change in DNA. 
Therefore, it could also be possible that oxidatively modified bases of RNA/DNA 
might be contributing towards the production of autoantibodies. 
Based on the above studies, the following conclusions can be drawn. 
1. The photochemical modification of poly(I) resulted in the formation of 
strand breaks and modification of hypoxanthine base as assayed by physico-
chemical techniques. 
2. Hypoxanthine was found to be modified to an extent of 72%. 
3. The photomodified conformer is thermodynamically more stable as 
compared to the native form. 
4. Both the native and ROS-modified poly(I) are highly immunogenic in 
experimental animals. 
5. The induced antibodies show polyspecificity. 
6. Anti-native poly(I) antibodies show preferential recognition to the native 
conformations of the polynucleotides over their ROS-modified counterparts. 
7. Specificity of anti-ROS-poly(I) antibodies is more towards ROS-modified 
polynucleotides in comparison to native forms. 
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8. The polyspecific behaviour of anti-ROS-poly(I) antibodies resembles the 
binding characteristics of SLE anti-DNA autoantibodies. 
9. ROS-poly(I) presents a discriminating antigen for the binding of SLE 
autoantibodies. 
10. The binding affinity of ROS-poly(I) for SLE autoantibodies is maximum, 
followed by native DNA and native poly(I) respectively. 
11. In comparison to native DNA, ROS-poly(I) provides greater inhibitory 
potential to SLE anti-DNA autoantibodies which points out the presence 
of unique potential epitopes on modified poly(I). 
12. It is suggested that reactive oxygen species modified nucleic acids might be 
challenging the immune system leading to autoantibody production. 
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